BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261109T113000
DTEND;TZID=Europe/Stockholm:20261110T123000
DTSTAMP:20261109T092956Z
CREATED:20260413T092109Z
LAST-MODIFIED:20261109T092956Z
UID:10001800-1794223800-1794313800@www.scilifelab.se
SUMMARY:DDLS Annual Conference 2026
DESCRIPTION:The Data-Driven Life Science (DDLS) program\, funded by the Knut and Alice Wallenberg Foundation (KAW)\, warmly welcomes you to the 5th DDLS Annual Conference\, taking place November 9-10\, 2026\, at Aula Magna\, Frescati Campus\, Stockholm. \n\n\n\nTarget Group: Anyone interested in data-driven life science is welcome to attend the Conference. You don´t need to be part of the SciLifeLab & Wallenberg National Program for Data-Driven Life Science\, even though the conference focuses on achievements and highlights program activities. \n\n\n\nThis two-day\, in-person event will highlight DDLS research and activities\, showcase new technologies and services available to researchers across Sweden\, and provide a forum for knowledge exchange and collaboration. Participants will have the opportunity to: \n\n\n\n\nShare and discuss research findings\n\n\n\nExplore ideas and insights across disciplines\n\n\n\nBuild networks for collaboration and career development\n\n\n\nGain perspectives beyond their own fields of expertise\n\n\n\n\nHosts & Moderators\n\n\n\nThe DDLS & SciLifeLab Director\, Jan Ellenberg\, will open the 2-day Conference. The DDLS Co-Directors\, Erik Kristansson (Chalmers) and Carolina Wählby (Uppsala University)\, will moderate and guide you through the Program. \n\n\n\nThe conference begins on November 9 with on-site registration and poster hanging from 11:00\, a light networking lunch from 11:30 to 12:30\, and concludes with a networking lunch on November 10 (12:30–13:30). \n\n\n\nKeynotes\n\n\n\n\n\nAndreas KapouraniDirector of Data Science at Relation TherapeuticsRelation Therapeutics\n\n\n\n\n\nKaroline FaustAssociate Professor and head of the Lab of Microbial Systems BiologyKU Leuven\n\n\n\n\n\n\n\n\n\n\nYouTube live-broadcast\n\n\n\nYouTube broadcast: The Program from Aula Magna will be live-broadcast on the YouTube SciLifeLab Talks & Training channel. Note! Some speakers may share unpublished data that will be excluded from the live broadcast. You will find an embedded YouTube video player here on the day of the event. \n\n\n\n\nProgram\n\n\n\nNovember 9\n\n\n\n11:00Registration opens. Hang your poster according to the Poster list.11:30Light lunch12:30Introduction and WelcomeJan Ellenberg\, DDLS and SciLifeLab Director12:50Three Impactful Problems in Drug Discovery That Might Be Solvable with Machine Learning (and What We Are Doing About Them at Relation Therapeutics)Andreas Kapourani\, Director of Data Science\, Relation Therapeutics\, UK13:30Panel DiscussionModerators: Ola Engkvist\, Executive Director AstraZeneca & Adjunct Professor Chalmers University of Technology; Tuuli Lappalainen\, Professor\, KTH/SciLifeLab1. Gianfranco Grompone\, PhD\, CSO\, BioGaia AB & Affiliated Scientist\, University of Gothenburg2. Lina Hultin Rosenberg\, Director Data & Analytics\, R&D\, Olink / Thermo Fisher3. Peetra Magnusson\, Assoc. Prof. & DDLS Research School Director\, Uppsala University4. Patrik Rydén\, Prof. & IDS Director\, Umeå University5. Andreas Kapourani\, Director of Data Science\, Relation Therapeutics\, UK14:00Poster session I (odd numbers) with Coffee15:00DDLS Fellows talksUnderstanding Cancer Heterogeneity Through Machine Learning and Molecular NetworksGolnaz Taheri\, KTHPredictors of genome-wide variation in the effects of new mutationsJennifer James\, UUTowards autoregularization of reconstruction and datamining in cryo-EMBjörn Forsberg\, LiU.This talk will not be broadcast16:00Meet the new DDLS Fellows16:15HPC\, AI and Data Resources for Life Science ResearchMatts Karlsson\, NAISS Director of External Relations16:30Poster session II (even numbers) with Mingle17:30End of day 1\n\n\n\nNovember 10\n\n\n\n09:00DDLS Fellows talks09:05Leveraging population genomic data to understand clonal hematopoiesis and blood cancer riskAbhishek Niroula\, GUThis talk will not be broadcast09:25Steering AlphaFold through the distogramNicholas Pearce\, UU09:45Exploring chemical space with distillation modelsAndreas Luttens\, KIThis talk will not be broadcast10:05Coffee break10:50Top-Down and Bottom-Up Exploration of Alternative Community Types in the Human Gut MicrobiomeKaroline Faust\, Associate Professor\, KU Leuven\, Belgium11:30Presentations of DDLS funded projectsThe project presentations will not be broadcastLearning 3D genome dynamics from heterogeneous dataJohan Elf\, UUMultimodal AI-based Precision Diagnostics and Decision Support for Breast Cancer (AID4BC)Mattias Rantalainen\, KITIMED: Time-Resolved Imaging and Multi-Channel Evaluation of Cellular DynamicsRocio Mercado\, Chalmers; Ola Spjuth\, UUMicroscopy Foundation Model & AI-Ready Data Hub for Smart MicroscopyHanzhao Zhang\, KTHSwedish Metabarcoding Network (SMN)Tobias Andermann\, UUTissUUmaps RDCPCarolina Wählby\, UUCRITICAL MICROBES – Comprehensive Research on InfecTIons Complications Across the Lifespan – MICROBiology Epidemiology in SwedenAnne-Marie Connolly\, UmU12:15Best Poster Award & Closing Words12:30Lunch and networking13:30End of conference13:30Pre-registered workshop organized by SciLifeLab Data Centre:How to use LLMs to present results from your research project as a web application\, Meeting room Spelbomskan.\n\n\n\nSee separate registration page to sign up for workshops on November 10. \n\n\n\nProgram_DDLS Annual Conference 2026Download\n\n\n\nKeynotes\n\n\n\nAndreas Kapourani\nTitle: Three impactful problems in drug discovery that might be solvable with machine learning (and what we are doing about them at Relation Therapeutics).Bio: Andreas C. Kapourani is Director of Data Science at Relation Therapeutics\, where he leads the ML for Genetics group. In support of Relation’s vision to develop transformative medicines through a deeper understanding of disease biology\, his team develops DNA foundation models and specialised machine learning methods to understand how genetic variation influences gene regulation\, cellular function\, and disease. By integrating large-scale human genetics with single-cell and patient-derived multi-omics data\, their research aims to translate genetic associations into biological insights\, improving confidence in therapeutic target identification and guiding drug discovery.With a background in computer science and artificial intelligence\, Andreas holds a PhD in Data Science from the University of Edinburgh\, where he specialised in Bayesian modelling of single-cell and multi-omics data. Prior to joining Relation\, he was a Research Fellow at the University of Edinburgh\, where he developed statistical and machine learning approaches for single-cell and spatial genomics\, applying them to understand liver fibrosis and regeneration. His research has been published in journals including Nature\, Cell\, and Genome Biology. \n\n\n\n\nKaroline Faust\nTitle: Top-down and bottom-up exploration of alternative community types in the human gut microbiome.Bio: Karoline Faust is an Associate Professor at KU Leuven who heads the Lab of Microbial Systems Biology\, which focuses on investigating microbial community dynamics in silico and in vitro. In particular\, her team is studying interactions between human gut bacteria and the resulting dynamics with synthetic communities in controlled conditions. In addition\, the team develops new tools for the analysis of microbiome data\, specifically the analysis of microbial networks. The group’s work is thus situated at the intersection of bioinformatics\, systems biology\, and microbial ecology.Abstract: The human colon is home to a diverse microbial community\, the gut microbiome\, which impacts the host’s health and well-being. The composition of the gut microbiome varies across persons\, forming distinct groups known as enterotypes\, which have been linked to differences in host characteristics and behavior such as diet. However\, these environmental factors do not explain observations of transient perturbations leading to community shifts\, which persist even after the perturbation ceased. In my talk\, I will discuss multi-stability as an alternative hypothesis to explain enterotypes. I will present simulations and in vitro experiments that support the idea that alternative community types observed in the gut can be interpreted as different states of a multi-stable community. Investigating the causes behind alternative community types is relevant\, since they affect the interpretation of microbiome data. In particular\, multi-stability implies that different gut microbial community compositions can be due to past perturbations rather than current differences between hosts.Affiliation: Molecular Bacteriology Unit (Rega Institute)\, Department of Microbiology\, Immunology and Transplantation\, KU Leuven \n\n\n\n\nMatts Karlsson\nTitle: HPC\, AI and Data Resources for Life Science Research \n\n\n\nBio: Matts Karlsson is Professor of Applied Thermodynamics and Fluid Mechanics at Linköping University and a member of the steering group of the SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS). He has led national computing infrastructure for more than two decades: he was Director of the National Supercomputer Centre (NSC) at Linköping University in 2002–2003\, and again from 2016\, a period that included the inauguration of Tetralith\, then Sweden’s largest supercomputer. He later served as Deputy Vice-Chancellor for Research at Linköping University\, where he championed strategic investments in data\, AI and research infrastructure\, and he is now Director of External Relations at the National Academic Infrastructure for Supercomputing in Sweden (NAISS)\, working on partnerships with national research infrastructures such as MAX IV. His own research bridges computation and medicine: he develops patient-specific models of cardiovascular blood flow\, combining large-scale simulation with 4D flow MRI to understand diseases of the heart and aorta. \n\n\n\nAbstract: \n\n\n\nAffiliation: NAISS Director of External Relations \n\n\n\n\n \n\n\n\nDDLS Fellows Talks\n\n\n\nBjörn Forsberg\nTitle: Towards autoregularization of reconstruction and datamining in cryo-EM \n\n\n\nBio: Researcher in structural biology and method development in cryo-EM \n\n\n\nAbstract: Cryo-EM is the method of choice for visualization of proteins and biomolecules with molecular detail\, permitting multiple states\, binding partners and molecular motions to be visualized with more flexibility than other methods. However\, this is highly dependent on the sample and conditions\, and the wide range of use cases and application details creates a necessity for data processing to be adaptive. Historically\, this has relied on expert users to inject reasonable bias into the processing pipeline\, using deep technical knowledge and elaborate specialized pipelines. Here I will present an overview of how we aim to provide more adaptive control of the data processing\, through construction of natural features that decrease bias with increased meaningful regularization. This also requires a new framework for evaluating performance and better synthetic data for legitimate ground-truth evaluation of current methods of data processing. \n\n\n\nAffiliation: Linköping University \n\n\n\n\nAbhishek Niroula\nTitle: Leveraging population genomic data to understand clonal hematopoiesis and blood cancer risk \n\n\n\nBio: Abhishek Niroula is a DDLS Fellow and Assistant Professor at the University of Gothenburg. He received his PhD from Lund University\, where he studied the impact of genetic variation on human health. During his first postdoctoral appointment\, he worked in computational functional genomics to understand the functional impact of genetic variants identified through genome-wide association studies. He subsequently joined the Broad Institute\, where his postdoctoral research focused on pre-cancerous somatic mutations and the development of models to predict an individual’s risk of developing blood cancer. His laboratory at the University of Gothenburg now investigates the biology of pre-cancerous clones\, the mechanisms that regulate their expansion\, and how these clones contribute to human diseases\, including cancer and cardiovascular disease. \n\n\n\nAbstract: Cancer develops through the gradual accumulation of somatic genetic alterations and clonal evolution\, often over many years. Large-scale genomic and health datasets provide new opportunities to detect these changes at an early stage and identify individuals at increased risk of disease. Our lab studies clonal hematopoiesis\, an age-associated expansion of blood cell clones carrying somatic genetic mutations. Clonal hematopoiesis is associated with an elevated risk of blood cancers as well as non-malignant conditions\, including cardiovascular disease. Using genomic data from large population-based cohorts\, we characterize clonal hematopoiesis in individuals without blood cancer and investigate the genetic drivers and regulators of clonal expansion. By integrating genomic information with demographic\, clinical\, and longitudinal health data\, we investigate the factors that influence malignant transformation and develop models for predicting future blood cancer risk. Ultimately\, our work seeks to improve our understanding of the earliest stages of cancer evolution and provide a foundation for identifying individuals who may benefit from closer monitoring or early intervention. \n\n\n\nAffiliation: Department of Medical Biochemistry and Cell Biology\, Institute of Biomedicine\, Sahlgrenska Academy\, University of Gothenburg\, Gothenburg\, Sweden Science for Life Laboratory\, University of Gothenburg\, Gothenburg\, Sweden \n\n\n\n\nNicholas Pearce\nTitle: Steering AlphaFold through the distogram \n\n\n\nBio: Nicholas Pearce is a DDLS Fellow at Uppsala University working on method development within structural biology\, particularly for the identification of weak and dynamic signals in X-ray crystallography and Cryo-EM data. \n\n\n\nAbstract: Since its publication in 2021\, the networks within AlphaFold2/3 have been prodded and probed to understand how to steer the predicted structures to contain desirable features. We now have several methods that allow the imposition of external restraints on the structure predictions\, whether geometric priors or experimental data. However\, existing methods either use a sample-and-prune approach or else the restraint is a weak prior and can be ignored during structure prediction. We present a method for directly optimizing the pair representation within AlphaFold-like structure predictors to produce desirable features in the distogram\, which can be intuitively linked to different kinds of structural restraint. We demonstrate this “resTrain” method in a variety of applications including conformer generation\, docking\, and NMR structure determination. \n\n\n\nAffiliation: Department of Cell and Molecular Biology\, Uppsala University \n\n\n\n\nGolnaz Taheri\nTitle: Understanding Cancer Heterogeneity Through Machine Learning and Molecular Networks \n\n\n\nBio: Golnaz Taheri is an Assistant Professor and Docent at KTH Royal Institute of Technology and a research group leader at SciLifeLab. She is a WASP and DDLS Fellow and a member of the Digital Futures faculty. Her research focuses on developing machine-learning methods for complex biomedical data\, particularly graph-based modelling and multimodal data integration. Her group combines methodological development with applications in cancer genomics\, drug interactions and response\, with an emphasis on biological interpretation. \n\n\n\nAbstract: Cancer heterogeneity reflects both molecular differences within tumours and interactions between cancer cells and their surroundings. In this talk\, I will discuss how machine learning and network modelling can help study this complexity\, drawing on breast and prostate cancer research and ongoing work investigating how cancer–fibroblast interactions influence responses to drug perturbations. The main focus will be our framework for prioritising candidate regulatory genes in breast cancer. Rather than analysing all tumours through a shared molecular network\, we infer a separate regulatory network for each breast cancer subtype and combine gene-expression features with information about each gene’s position in the network. I will present how our findings recover known cancer genes and subtype-relevant biological pathways\, and highlight a candidate gene in one of the breast cancer subtypes\, where its expression is associated with patient outcomes. Through these examples\, I will discuss the contribution of network structure to gene prioritisation and the biological interpretation of cancer heterogeneity across molecular and cellular scales. \n\n\n\nAffiliation: Department of Computational Science and Technology\, School of Electrical Engineering and Computer Science\, KTH Royal Institute of Technology\, and Science for Life Laboratory (SciLifeLab)\, Stockholm\, Sweden. \n\n\n\n\nJennifer James\nTitle: Predictors of genome-wide variation in the effects of new mutations \n\n\n\nBio: As a researcher\, I’m fascinated by new mutations; these provide the vital raw material necessary for evolution and adaptation. New mutations occur regularly\, generating genetic diversity- new heritable variation among individuals. However\, how many of these new mutations generate variation in the traits of the individuals that carry them? And\, most importantly for evolution by natural selection\, how do new mutations impact fitness\, the ability of individuals to survive and reproduce? My work seeks to address these important questions\, using a combination of population genetics and proteomics. \n\n\n\nAbstract: In our recent work\, we assessed how predictive gene features (such as local recombination rate\, level of organisation within gene gene networks\, and gene length) are to the level of selective constraint genes experience\, and assessed how this impacts the effects that new mutations have on such genes. We used data from the full genomes of Mus musculus castaneus (mouse)\, Drosophila melanogaster (fruit fly) and Saccharomyces cerevisiae (yeast)\, and a combination of population genetics and machine learning inference methods. We found that genes with higher connectivity in gene interaction networks and higher levels of expression were under greater selective constraint\, and new mutations in such genes had the strongest deleterious effects.  Our results highlight the value of using gene features collectively to link the genomic architecture\, fitness landscapes\, and patterns of molecular evolution. We also found that genes with the highest proportion of fixed beneficial mutations and therefore the highest rates of adaptive evolution tended to be those that have intermediate levels of selective constraint- i.e.\, not those genes that are under extremely strong negative selection but also not the genes under low levels of selective constraint. These are perhaps the genes in a ‘happy middle ground’- mutations in these genes are able to effect moderate phenotypic change when adaptive evolution is required\, but not so much change that they risk disrupting many systems at once. \n\n\n\nAffiliation: DDLS fellow Uppsala University \n\n\n\n\nAndreas Luttens\nTitle: Exploring Chemical Space with Distillation Models \n\n\n\nBio: Andreas earned his degree in chemistry from Ghent University\, Belgium\, before completing a PhD in molecular life sciences at Uppsala University\, where he developed computational approaches to explore large chemical databases for novel drug candidates. He then joined MIT as a Wallenberg postdoctoral fellow\, focusing on deep learning methods to discover new antibiotics against drug-resistant bacteria. Recently appointed as an Assistant Professor\, Data-Driven Life Science Fellow\, and MIMS Investigator at Karolinska Institutet\, SciLifeLab\, and Umeå University\, Andreas leads a lab that harnesses deep learning models to design next-generation anti-infectives. \n\n\n\nAbstract: Discovering molecules with the right properties is a central challenge in drug design. While high-throughput screening can test thousands to millions of compounds\, even large internal collections represent a tiny fraction of accessible chemical space\, and the most promising candidates are often not among them. Scaling up to billion-compound make-on-demand libraries requires deep learning models that generalize well from limited experimental data. In this talk\, I will present GLACIER\, a multimodal foundation model designed for exactly this low-data regime. By combining complementary molecular representations and distilling knowledge from large pretrained models into a lightweight architecture\, GLACIER learns rich embeddings that transfer effectively to new tasks with few labels. I will show how this approach enables robust molecular property prediction and discuss its potential to prioritize synthesis candidates across billion-scale chemical libraries. \n\n\n\nAffiliation: Karolinska Institutet\, SciLifeLab\, Umeå University \n\n\n\n\n\n\n\n\nPoster Abstracts & DDLS Annual Poster Prize\n\n\n\nThe DDLS Poster Prize encourages PhD students and postdoctoral researchers to present high-quality work in data-driven life science. The award\, decided by a Scientific Committee jury\, includes a certificate and a travel grant of up to 5\,000 SEK. Conditions apply. If you present a poster\, please ensure you stay for the Poster Award Ceremony at 12:00 by the end of the Conference. \n\n\n\nPoster abstract book\n\n\n\n\n\n\n\nSatellite meetings (only invited)\n\n\n\nDDLS Research School kickoff meeting\, November 9\, 09:00-11:30. Meeting room: Bergsmannen. Registration and fika outside the meeting room from 08:30. \n\n\n\nDDLS Postdoc meeting\, November 9\, 10:30-11:30. Meeting room Mimer. \n\n\n\nDDLS Steering Group meeting\, November 10\, 13:00-14:30. Meeting room Polstjärnan. \n\n\n\nDDLS Fellows meeting\, November 10\, 13:30-16:00. Meeting room Bergsmannen. \n\n\n\nWorkshop: (only registered) How to use LLMs to present results from your research project as a web application\, arranged by SciLifeLab Data Centre. November 10\, 13:30-15:30. Meeting room Spelbomskan. \n\n\n\nRegistration\n\n\n\nRegistration and Poster submission are closed! \n\n\n\nSince we expect some cancellations between the deadline (October 21) and the event date\, we will keep “late-participant registration” possible. We have now closed the registration form. If you are interested\, you can come to Aula Magna and register on-site. BUT NOTE! \n\n\n\nA) We cannot accommodate allergies or dietary preferences.  \n\n\n\nB) We can only offer refreshments and lunch if we have the same amount of cancellations. Select your attendance for Lunch and poster mingle\, but please check with the on-site registration desk to see if coffee and lunch are available.  \n\n\n\n\n\n\n\nPractical information\n\n\n\nFind you way to Aula Magna\, Campus Frescati\n\n\n\nAula Magna is located close to public transport. The nearest stop is Universitetet\, served by the underground\, Roslagsbanan and several bus routes. Map to Aula Magna here! \n\n\n\n \n\n\n\nFind your way in the building\n\n\n\n4th floor (the Foyer)Registration\, Cloakroom\, exhibitors\, and two accessible toilets.Entrances A and B lead into the auditorium. \n\n\n\n5th floor (the Gallery)Catering and exhibitors. Entrance E leads into the auditoriumThere is a lift into the building from Frescativägen 6. \n\n\n\nRoom map of Aula MagnaDownload\n\n\n\n\n\n\n\nDDLS Annual Conference Workshops 2026\n\n\n\nDuring the second day of the DDLS Annual Conference\, participants will have an opportunity to attend one of two workshops. The workshops are designed for researchers in data-driven life sciences at all career stages. \n\n\n\nEach workshop has a limited number of seats on a first-come\, first-served basis. Those registered after the limit is reached will be placed on a waiting list. The workshops will take place in various rooms at the Aula Magna. All workshops start at 13:30 and end 15:30. Coffee/tea and fika will be served during the workshops. \n\n\n\nFeel free to email datacentre@scilifelab.se with any questions about the workshops. \n\n\n\n \n\n\n\nRead more & register\n\n\n\nWorkshop 1. How to use LLMs to present results from your research project as a web application \n\n\n\nWorkshop 2. Public hosting of Shiny apps: hands-on workshop
URL:https://www.scilifelab.se/event/ddls-annual-conference-2026/
LOCATION:Aula Magna\, Frescativägen 6\, Stockholm\, 114 18 Stockholm\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2026/03/DDLS-pressmeddelande-2026-03-25_bild-scaled.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261106T100000
DTEND;TZID=Europe/Stockholm:20261106T120000
DTSTAMP:20261009T145519Z
CREATED:20261009T145341Z
LAST-MODIFIED:20261009T145519Z
UID:10001915-1793959200-1793966400@www.scilifelab.se
SUMMARY:Dynamic Interplay between Morphogenesis and Cell Differentiation during Development
DESCRIPTION:Speaker: Dr. Takefumi Kondo\, RIKEN Centre for Biosystems Dynamics Research\, Japan \n\n\n\nHost: Mats Nilsson and Christos Samakovlis\, Stockholm University/SciLifeLab \n\n\n\nAbstract \n\n\n\nEach organ acquires its characteristic form and function during embryogenesis through the coordinated processes of morphogenesis and cell differentiation. Although these physical and biochemical processes proceed simultaneously\, it remains unclear how they interact to achieve the precise coordination required for proper organ development and function. We previously reported that\, during tracheal development in Drosophila embryos\, several mutants with defects in placode invagination show a reduction in the number of placode cells that successfully invaginate. In both wild-type embryos and these mutants\, only placode cells that do invaginate differentiate into tracheal cells\, whereas those that remain on the embryo surface differentiate into epidermal cells. This finding suggests that cell fate is not fully determined at the initial stage of placode induction\, but instead remains flexible and can be adjusted in response to subsequent changes in the chemical and physical environment. Such plasticity may provide a mechanism by which the final differentiation state is precisely coordinated with tissue architecture. \n\n\n\nWe recently found that transient expression of the Pri micropeptide in tracheal placodes plays an important role in the transition from signal-guided fate induction to fate maintenance. In addition\, invaginated tracheal cells\, despite expressing the transcriptional repressor Svb\, escape its repressive effects and maintain tracheal gene expression\, suggesting that the context-dependent activity of this repressor may contribute to coordinating cell-fate regulation with morphogenesis. To further explore the crosstalk between morphogenesis and cell differentiation\, we are also aim to quantitatively capture the spatiotemporal dynamics of cell differentiation. To this end\, we are establishing a comprehensive time-course single-cell RNA-seq dataset and an in-house highly multiplexed whole-mount FISH platform. In this presentation\, I will introduce these resources and experimental approaches and discuss the spatiotemporal relationship between morphogenesis and cell differentiation during embryogenesis. \n\n\n\nBiography \n\n\n\nDr. Takefumi Kondo is Team Director of the Laboratory for Developmental Genome System at the RIKEN Center for Biosystems Dynamics Research in Kobe\, Japan. His research aims to understand how embryonic development proceeds with remarkable precision and robustness\, with a particular focus on the interplay between cell differentiation and tissue morphogenesis. Using Drosophila embryogenesis as a model\, his group combines genetics\, imaging\, and single-cell/spatial genomics to investigate developmental processes across multiple scales\, from genome function to tissue organization.
URL:https://www.scilifelab.se/event/dynamic-interplay-between-morphogenesis-and-cell-differentiation-during-development/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261104T090000
DTEND;TZID=Europe/Stockholm:20261104T170000
DTSTAMP:20261029T125840Z
CREATED:20260424T070749Z
LAST-MODIFIED:20261029T125840Z
UID:10001808-1793782800-1793811600@www.scilifelab.se
SUMMARY:Living systems across scales
DESCRIPTION:RIKEN – KI – SciLifeLab Symposium 2026\n\n\n\nThe RIKEN – KI – SciLifeLab Joint Symposium 2026 will bring together leading researchers from Japan and Sweden to explore how complex biological systems can be understood across spatial\, temporal\, and functional scales. \n\n\n\nThe 2026 theme\, Living systems across scales\, focuses on integrating insights from molecular and cellular biology to tissues\, organs\, and whole organisms. Particular emphasis will be placed on emerging technologies and approaches\, including spatial omics\, advanced imaging\, and data-driven methods for linking phenotype to function. \n\n\n\nThe symposium is intended for researchers working across life science disciplines\, including molecular biology\, genomics\, bioinformatics\, imaging\, and systems biology\, as well as those interested in interdisciplinary and translational perspectives. \n\n\n\n \n\n\n\nThe event is fully booked. \n\n\n\nDeadline for registration with poster presentation: October 15. Please note that you may still register also after this deadline\, but we will not accept more poster submissions. \n\n\n\n \n\n\n\nProgram\n\n\n\nTimeActivity08:30Registration09:00Opening remarksDr. Jan Ellenberg\, SciLifeLab\, DirectorDr. Martin Bergö\, Karolinska Institutet\, Vice PresidentDr. Masayuki Amagai\, RIKEN IMS\, DirectorSession 1: Spatial OmicsChair: Chung Chau Hon\, RIKEN IMS09:15A spatial and molecular view of temporal events in development and cancerDr. Joakim Lundeberg\, SciLifeLab (KTH)09:40Functional analysis of sensory neuronal subsets in the barrier organsDr. Takaharu Okada\, RIKEN IMS10:05A novel approach for single cell-based 3D spatial omicsDr. Katsuyuki Shiroguchi\, RIKEN BDR10:30Coffee BreakSession 2: Tissue microenvironment and developmentChair: Andreas Lennartsson\, Karolinska Institutet11:00Multiscale dynamics and mechanics of the basement membrane in epithelial morphogenesisDr. Hironobu Fujiwara\, RIKEN BDR11:25Claudin-dependent clonal expansion couples activation to acquisition of regenerative competenceDr. Elif Eroglu\, Karolinska Institutet11:50Neural Coding and Information Processing in Spinal CircuitsDr. Aya Takeoka\, RIKEN CBS12:15Towards a blueprint of life: an omics-scale approach to resolve mammalian developmentDr. Emma Andersson\, Karolinska InstitutetSession 3: Poster pitchChair: Maria Kasper\, Karolinska Institutet12:40Poster pitch: 1 minute per poster13:10Lunch Break & Poster sessionSession 4: Human genomics and diseaseChair: Carsten Daub\, SciLifeLab (Karolinska Institutet)14:40Functional variation in the human genome: Linking gene dosage to molecular and disease phenotypesDr. Tuuli Lappalainen\, SciLifeLab (KTH) & NY Genome Center15:05From snapshots to dynamics: single-cell genomics of neuropsychiatric disordersDr. Atsushi Takata\, RIKEN CBS15:30The hidden genetics of human adaptive immunityDr. Gunilla Karlsson Hedestam\, Karolinska Institutet15:55Coffee BreakSession 5: Metabolomics and ProteomicsChair: Craig Wheelock\, Karolinska Institutet16:25Biology of LipoQuality and the Lipidome AtlasDr. Makoto Arita\, RIKEN IMS16:50The dawn of single-cell proteomics to map tissue diversityDr. Florian Rosenberger\, SciLifeLab (Karolinska Institutet)17:15Closing remarksDr. Kyoko Nozaki\, RIKEN\, Executive Vice PresidentDr. Ryoichiro Kageyama\, RIKEN BDR\, Director17:25Mingle
URL:https://www.scilifelab.se/event/riken-ki-scilifelab-symposium-2026/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261021T151500
DTEND;TZID=Europe/Stockholm:20261021T160000
DTSTAMP:20261008T072623Z
CREATED:20261005T143729Z
LAST-MODIFIED:20261008T072623Z
UID:10001909-1792595700-1792598400@www.scilifelab.se
SUMMARY:SciLifeLab Training strategy hearing
DESCRIPTION:During 2026\, a SciLifeLab Training Strategy has been developed by a working group lead by SciLifeLab management\, including representatives from Data Centre\, DDLS Research School\, Fellows\, Infrastructure\, Operations Office and Training Hub\, informed by a community survey and dialogue with SciLifeLab stakeholders. The strategy is planned for approval by the Board in November. Before then\, the SciLifeLab community is invited to provide input on the strategy document. \n\n\n\nThe process and strategy will be presented by Mia Phillipson\, SciLifeLab Co-Director and Disa Hammarlöf\, coordinator of the strategy work.Prior to the hearing\, the close-to-final Training strategy will be shared with registered participants\, who will get the chance to submit questions ahead of as well as during the event. \n\n\n\n\nLink to registration
URL:https://www.scilifelab.se/event/scilifelab-training-strategy-hearing-2/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20261014T083000
DTEND;TZID=Europe/Stockholm:20261014T170000
DTSTAMP:20261013T125417Z
CREATED:20251219T121224Z
LAST-MODIFIED:20261013T125417Z
UID:10001689-1791966600-1791997200@www.scilifelab.se
SUMMARY:SciLifeLab Science Summit
DESCRIPTION:The Annual Conference SciLifeLab Science Summit is a one-day symposium with a new topic each year. The 2026 topic is: \n\n\n\nCancer Research: Translating Life Science Discoveries to Clinical Breakthroughs\n\n\n\nFor more than a century\, Swedish cancer research has shaped the international scientific landscape\, driven by strong academic environments and a deep societal commitment to transforming discoveries into better treatments. From breakthroughs in cancer genomics and tumor biology to advances in immunology and angiogenesis\, researchers in Sweden continue to push the boundaries of life science and medicine. \n\n\n\nThe SciLifeLab Science Summit brings this legacy into the future by uniting world-leading cancer researchers with cutting-edge technologies across genomics\, proteomics\, imaging\, data science\, and beyond. The summit creates an inspiring forum where scientific excellence meets societal relevance—fostering collaboration\, showcasing groundbreaking research\, and highlighting how cancer research continues to reveal fundamental mechanisms of life while driving innovation with real-world impact. \n\n\n\nThe conference is free of charge. Fika\, lunch and Meet-the-speaker-mingle will be included (only) if you register before deadline on September 21. \n\n\n\nJoin us for a full day of inspiring Science! \n\n\n\nWelcome! \n\n\n\nScientific Committee\n\n\n\n\n\n\n\nProject leader: Erika Erkstam\, Operations Office\, SciLifeLab \n\n\n\nRegistration\n\n\n\nREGISTRATION HAS CLOSED! Poster submissions are no longer accepted.  \n\n\n\nUpdate 2026-10-13: If you are interested in listening to the Lectures\, feel free to come by even if you haven´t registered. When you arrive\, please head to the Late Registration desk\, where we will prepare a name badge for you. As registration has already closed\, we are unfortunately unable to guarantee fika or lunch.  \n\n\n\nArrival and registration\n\n\n\nRegistration opens at 08:30. Please arrive early to allow time for registration\, collection of your name badge\, and use of the cloakroom. \n\n\n\n\nRegistration: Ground floor (entrance level)\n\n\n\nCloakroom: One floor below the entrance level\n\n\n\nLecture Hall: Top floor (Level 6)\n\n\n\n\nDoors to the lecture hall open at 09:00. The program starts promptly at 09:15\, and we ask all participants to be seated by then. \n\n\n\nStrong interest in this year’s Summit \n\n\n\nWith nearly 500 participants registered\, interest in this year’s Summit has exceeded our expectations. During coffee and lunch breaks\, please help us keep things running smoothly by collecting your food and refreshments efficiently and making room for others once served. \n\n\n\nWe encourage you to use these breaks to explore the poster exhibition and connect with fellow participants and continue the scientific discussions throughout the day. \n\n\n\nQuestions? If you have any inquiries regarding the event or your registration\, please contact events@scilifelab.se \n\n\n\nSpeakers\n\n\n\n\nAngelica Loskog\, Uppsala University and Lokon Pharma\, Sweden\n\n\n\nAnna Martner\, University of Gothenburg\, Sweden\n\n\n\nAri Molofsky\, University of California\, San Francisco\, US\n\n\n\nBernd Bodenmiller\, University of Zurich and ETH Zurich\, Switzerland\n\n\n\nGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, Belgium\n\n\n\nGunilla Enblad\, Uppsala University and Uppsala University Hospital\, Sweden\n\n\n\nGöran B. Jönsson\, Lund University\, Sweden\n\n\n\nIñaki Martin-Subero\, ICREA Research Professor at IDIBAPS\, Barcelona\, Spain\n\n\n\nThoas Fioretos\, Lund University\, Sweden\n\n\n\n\nProf. Angelica Loskog\nUppsala University\, Sweden and Lokon Pharma. \n\n\n\nTitle: Evoking Tumor Immunity in Immune-Resistant Cancers  \n\n\n\nBiosketch: Angelica Loskog is a professor of immunotherapy at Uppsala University and the CEO of Lokon Pharma AB. She is also a board member of several biotech companies including Lokon Pharma\, RePos Pharma\, Medivir (Publ)\, and KDVentures (Publ). Her research focuses on gene engineering of the tumor microenvironment using adenoviruses (replication deficient and oncolytic) to promote in vivo expansion of tumor-reactive T cells. She develops novel products from bench to bedside\, academically or in collaboration with suitable pharma partners. \n\n\n\nAbstract:  \n\n\n\nGrauers Wiktorin H1\, Lövgren T1\, Wenthe J1\, Ritter A1\, Calandegary A1\, Ekström Ryden V\,1\,2 Hahn A1\,2\, Hamid O3\, Gustafsson Liljefors M4\, Musher BL5\, Brenner MK5\, Ullenhag G1\,2\, Loskog A1\,6. \n\n\n\n1Uppsala University\, Uppsala\, Sweden \n\n\n\n2Uppsala University Hospital\, Uppsala\, Sweden \n\n\n\n3The Angeles Clinic and Research Institute\, A Cedars Sinai Affiliate\, Los Angeles\, CA\, USA \n\n\n\n4Karolinska Hospital\, Huddinge\, Sweden \n\n\n\n4Baylor College of Medicine\, Houston\, TX\, USA \n\n\n\n6Lokon Pharma AB\, Uppsala\, Sweden \n\n\n\nImmunotherapy for cancer is a cornerstone of cancer treatment but despite the initial success\, many patients are either primary resistant or develop resistance during treatment. By engineering the tumor microenvironment using and oncolytic adenoviral gene vector encoding TMZ-CD40L and 4-1BBL (LOAd703)\, we aim to rewire the immunosuppressive state in the patients to drive anti-tumor immune responses allowing for continued immune checkpoint inhibitor (ICI) treatment of refractor patients and/or ICI treatment of indications previously not responding to ICI. LOAd703 plus ICI have been tested in melanoma patients (n=24) refractory to one or several lines of prior ICI\, and in pancreatic cancer patients (LOAd703 +standard chemotherapy\, n=21; LOAd703 + ICI + standard chemotherapy\, n=24) who are commonly not responding to ICI. In these Phase I/II clinical trials blood and biopsies were analyzed for the initiation of immune responses locally in the tumor microenvironment as well as systemically in blood. \n\n\n\nThe treatment was well tolerated with common adverse events related to chemotherapy (pancreatic cancer) or ICI (melanoma and pancreatic cancer). LOAd703 attributed adverse events included fever\, chills\, and cytokine release syndrome\, mostly grade 1 or 2. Both in melanoma and pancreatic cancer\, LOAd703 promoted a typical Th1 type of immune response post treatment initiation which was noted both in the tumor and in blood. Similarly\, tumor responses were noted in both indications as evaluated with Olink proteomics\, NanoString Technology\, and flow cytometry. In conclusion\, LOAd703 can be used together with chemotherapy and/or ICI treatment to rewire the immunosuppressive state in patients towards Th1 immunity and subsequently controlling tumor growth in patients. \n\n\n\n \n\n\n\n\nProf. Anna Martner\nUniversity of Gothenburg\, Sweden.  \n\n\n\nTitle: NOX2-derived ROS as drivers of metastatic progression \n\n\n\nBiosketch: Anna Martner is a group leader at the Sahlgrenska Center for Cancer Research\, University of Gothenburg. Her research focuses on myeloid cell-mediated immunosuppression\, NOX2-derived ROS\, tumor cell plasticity\, and metastasis. She trained with Professors Kristoffer Hellstrand and Dmitry Gabrilovich and spent a 2019 sabbatical in Professor Robert Weinberg’s laboratory at MIT studying EMT. \n\n\n\nAbstract: The efficacy of cancer immunotherapy depends on the balance between anti-tumor effector cells\, including natural killer (NK) cells and T cells\, and mechanisms of tumor-associated immunosuppression. Inflammatory myeloid cells\, including myeloid-derived suppressor cells (MDSCs)\, contribute to immune evasion through several mechanisms\, among them the production of reactive oxygen species (ROS) by NOX2. \n\n\n\nOur group investigates the role of NOX2-derived ROS in cancer-associated immunosuppression and metastasis\, and the potential of targeting this pathway therapeutically. We have shown that genetic or pharmacological inhibition of NOX2 promotes NK cell-mediated clearance of metastatic tumor cells and enhances the efficacy of immune checkpoint blockade (Aydin et al.\, Cancer Immunol Res\, 2017; Grauers Wiktorin et al.\, Cancer Immunol Immunother\, 2019). We also found that surgical stress aggravates NOX2-dependent immunosuppression and metastatic progression\, effects that can be counteracted by NOX2 inhibition (Grauers Wiktorin et al.\, Cancer Res Commun\, 2024). \n\n\n\nMore recently\, we found that myeloid cell-derived NOX2-generated ROS can act directly on tumor cells. These ROS induce epigenetic changes that activate epithelial-to-mesenchymal transition (EMT) programs and promote metastasis (Kaya et al.\, PNAS\, 2026). Thus\, NOX2-derived ROS may promote metastatic progression both by suppressing anti-tumor immunity and by enhancing tumor cell plasticity. \n\n\n\nHistamine dihydrochloride (HDC)\, which inhibits NOX2-dependent ROS formation\, is approved in the EU for relapse prevention in acute myeloid leukemia. In an ongoing clinical trial at the Sahlgrenska University Hospital\, we are investigating HDC in combination with IL-2 in patients undergoing surgery for pancreatic cancer\, with the aim of reducing perioperative immunosuppression and metastatic risk. \n\n\n\n\nProf. Ari Molofsky\nUniversity of California\, San Francisco \n\n\n\nTitle: Fibroblast – Immune niches in health and disease. \n\n\n\nBiosketch: Ari Molofsky received a BS with highest honors from the University of Texas at Austin and an MD/PhD with research distinction from the University of Michigan in Ann Arbor. Dr. Molofsky completed residency and fellowship in Clinical Pathology/Hematopathology and now leads a tissue immunology-focused research group in the Department of Laboratory Medicine at UCSF. Dr. Molofsky’s research goals are to understand the regulation and function of tissue-resident immune cells to define novel pathways that can be targeted across diverse human diseases. These tissue-resident immune cells are early organizers of tissue remodeling and first responders during tissue damage and infection\, positioning them as key mediators of tissue health and disease. The Molofsky lab has defined a stromal-immune niche surrounding larger vessels and other border structures in multiple tissues\, including the lungs and brain. They are using 3D quantitative microscopy\, single-cell and spatial transcriptomics\, and cytokine reporters/manipulators to dissect these critical immune-microenvironment interactions\, with a particular focus on bidirectional interactions with fibroblasts. Dr. Molofsky has published papers spanning microbial pathogenesis\, tissue-resident immunity\, and local immune niches. Dr. Molofsky is actively involved in trainee education and teaching and leads the UCSF medical school immunology course. Dr. Molofsky routinely serves as an ad hoc reviewer for multiple journals and is a standing member of the NIH Innate Immunity study section. \n\n\n\nAbstract: Fibroblasts collaborate with immune cells to promote healthy organ regeneration and prevent scarring after injury. Although fibroblasts display organ-specific states and functions\, conserved functional states also exist that cross-regulate diverse immune cells and are governed by organ spatial cues. Here\, I will focus on our recent work in the brain and lung using models of sterile and infectious injuries. First\, I will discuss the conserved fibroblast-immune response to sterile brain injury\, in which we found that early pro-fibrotic myofibroblasts infiltrated brain lesions at subacute time points and were coordinated by fibroblast TGFβ signaling\, pro-fibrotic macrophages and microglia\, and perilesional glia. Myofibroblasts subsequently transitioned into multiple late states\, including de novo lymphocyte-interacting fibroblasts that supported long-term brain type 1-skewed lymphocytes. Interruption of this spatiotemporal response impaired brain wound healing and led to persistent neuroinflammation\, disrupted CNS lymphocyte niches\, and increased stroke mortality\, highlighting an unexpected role of fibroblasts as dynamic regulators of CNS healing and neuroinflammation after brain injury. In the second portion of my talk\, I will compare our findings in the brain with unpublished work focused on understanding how lung fibroblasts and their dynamic states cooperate with immune cells during viral infection with influenza A virus\, including efforts to understand how TGFb signaling regulates lung regulatory T cell ‘niches’ to ultimately tune the balance of inflammation and resolution after lung infection. Together\, the talk will provide an up-to-date perspective on fibroblast states and their immune interactions. \n\n\n\n\nProf. Bernd Bodenmiller\nUniversity of Zurich and ETH Zurich\, Switzerland \n\n\n\nTitle: Highly multiplexed imaging of tissues with subcellular resolution by imaging mass cytometry \n\n\n\nBiosketch: Bernd Bodenmiller is a quantitative biologist who develops novel experimental and computational approaches for the quantitative analysis of tumor ecosystems to improve our understanding of the mechanisms of tumor development for the benefit of patients. He is the founding director of the Department of Quantitative Biomedicine (DQBM) at the University of Zurich\, which fosters research and education at the interface of biomedical research\, biotechnology\, and computational biology to guide development of next-generation precision medicine. Prof. Bodenmiller obtained his PhD in the group of Ruedi Aebersold at ETH Zürich. For his postdoctoral training\, he joined the laboratory of Garry P. Nolan at Stanford University. In 2012\, he became a group leader and in 2013 an SNF/ERC assistant professor at the University of Zürich. In 2019\, he was tenured and became the founding director of the DQBM. In October 2020 Prof. Bodenmiller has been appointed as Dual Professor for Quantitative Biomedicine at the UZH and at ETH Zurich. His group pioneered the development of imaging mass cytometry\, an approach that enables simultaneously imaging of over 40 proteins and transcripts in tumor tissues (Nat. Methods\, 2014; Cell Systems\, 2017; Nature 2020) and the histoCAT software toolbox (Nat. Methods\, 2017). His groups applies these methods to unravel how cells in the tumor ecosystem drive cancer development to identify mechanisms that might be exploited for therapeutic targeting (Nat. Biotechnology\, 2017\, Cell\, 2017; Cell\, 2019). \n\n\n\nAbstract: Cancer is a tissue disease. Heterogeneous cancer cells and normal stromal and immune cells form a dynamic ecosystem that evolves to support tumor expansion and ultimately tumor spread. The complexity of this dynamic system is the main obstacle in our attempts to treat and heal the disease. The study of the tumor ecosystem and its cell-to-cell communications is thus essential to enable an understanding of tumor biology\, to define new biomarkers to improve patient care\, and ultimately to identify new therapeutic routs and targets. \n\n\n\nTo study and understand the workings of the tumor ecosystem\, highly multiplexed image information of tumor tissues is essential. Such multiplexed images will reveal which cell types are present in a tumor\, their functional state\, and which cell-cell interactions are present. To enable multiplexed tissue imaging\, we developed imaging mass cytometry (IMC). IMC is a novel imaging modality that uses metal isotopes of defined mass as reporters and currently allows to visualize over 50 antibodies and DNA probes simultaneously on tissues with subcellular resolution. In the near future\, we expect that over 100 markers can be visualized. We applied IMC for the analysis of breast cancer samples in a quantitative manner. To extract biological meaningful data and potential biomarkers from this dataset\, we developed a novel computational pipeline called histoCAT geared for the interactive and automated analysis of large scale\, highly multiplexed tissues image datasets. Our analysis reveals a surprising level of inter and intra-tumor heterogeneity and identify new diversity within known human breast cancer subtypes as well as a variety of stromal cell types that interact with them.In summary\, our results show that IMC provides targeted\, high-dimensional analysis of cell type\, cell state and cell-to-cell interactions within the TME at subcellular resolution. Spatial relationships of complex cell states of cellular assemblies can be inferred and potentially used as biomarkers. We envision that IMC will enable a systems biology approach to understand and diagnose disease and to guide treatment. \n\n\n\n\nProf. Gabriele Bergers\nVIB-KU Leuven Center for Cancer Biology\, Belgium \n\n\n\nTitle: A vascular perspective on immunity in cancer and inflammation \n\n\n\nBiosketch: Dr. Gabriele Bergers is a Professor of Oncology at the University of Leuven and a Principal Investigator at the Vlaams Instituut Voor Biotechnologie (VIB)-Center for Cancer Biology in Leuven since 2016. Prior\, she followed the faculty rank at the University of California\, San Francisco\, and was a Professor in the Department of Neurological Surgery and a PI in the Brain Tumor Research Center (BTRC) at the Helen Diller Family Comprehensive Cancer Center at the University of California\, San Francisco until 2016. \n\n\n\nThe overall research interest of her group relates to the tumor vasculature\, which entails an integral and critical component of the tumor microenvironment and closely interacts with distinct cell constituents of the heterogeneous tumor community. Such crosstalk is pivotal not only for the genesis and progression of a tumor but also for the tumor’s ability to resist therapeutic elimination. \n\n\n\nOver the last years\, her group has made seminal discoveries in the heterogenous crosstalk of the vascular immune axis and identified several intimate regulatory mechanisms between angiogenesis and immunosuppression that provide novel target possibilities to enhance the effects of cancer therapy by modulating the tumor vascular system and its communication with immune cells; among those\, to induce high endothelial venules and subsequent tertiary lymphoid structures\, with the overarching goal to sensitize and enhance an immune response in cancer patients to thwart tumors and metastases and invigorate tissue homeostasis. \n\n\n\nFor her research\, Dr. Bergers has received several awards\, including the Sidney Kimmel\, the Sandler Opportunity\, UCSF Breakthrough Biomedical Research\, and the Judah Folkman Award. She has acted as an external advisory board member for a number of universities and pharmaceutical companies; most recently for Mestag Therapeutics. Dr. Bergers was the co-director of the U54 Tumor microenvironment Brain Tumor Center at UCSF until 2016. She was  a Scientific co-founder of Oncurious. \n\n\n\nAbstract: The vasculature is a critical gatekeeper of tissue immunity\, determining which cells can enter or exit a tissue. During infection\, specialized endothelial cells known as high endothelial venules (HEVs)become activated to promote lymphocyte entry into lymph nodes\, enabling efficient immune priming against pathogens. In cancer\, however\, the vascular system is frequently reprogrammed to suppress immunity. Tumor endothelial cells can form barriers that limit lymphocyte infiltration\, contributing to immune-cold or immune-desert tumors. At the same time\, tumor cells actively remodel HEVs in tumor-draining lymph nodes\, altering their phenotype to facilitate tumor cell intravasation and systemic dissemination. \n\n\n\nRecent mechanistic insights into HEV regulation reveal that the vascular system can also be therapeutically reprogrammed. Induction of intratumoral HEVs can promote lymphocyte recruitment and the formation of tertiary lymphoid structures (TLS)\, which are associated with stronger anti-tumor immunity and improved clinical outcomes. In contrast\, chronic inflammatory diseases such as psoriasis also display HEV expansion accompanied by persistent T-cell aggregates\, where excessive lymphocyte influx may exacerbate pathology. \n\n\n\nHere\, I will discuss HEVs as central vascular regulators of local and systemic immune responses across cancer and chronic inflammation. I will highlight emerging strategies to modulate the vascular axis to either enhance anti-tumor immunity or dampen pathological inflammation\, positioning HEVs as promising therapeutic targets for restoring tissue immune homeostasis. \n\n\n\n\nProf. Gunilla Enblad\nUppsala University and Uppsala University Hospital \n\n\n\nTitle: CAR T-cells a powerful new immunotherapy \n\n\n\nBiosketch: Gunilla Enblad is professor of oncology at Uppsala university Hospital and Uppsala University and senior consultant in oncology. Her main research interests are lymphomas and CAR T-cells. She was PI for the first two academic CAR T-cell trials in Uppsala\, started already 2014 which was first in Europe. She is now PI for a third academic CAR T-cell trials for lymphomas. She is the chairman of the Swedish CAR T-cell group and co-chairman of SWECARNET\, a collaborative group on CAR T-cells. She is currently performing clinical and translational research on lymphomas and CAR T-cells. \n\n\n\nAbstract: Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment for relapsed and refractory malignancies and autoimmune disease. CAR T-cells are autologous T lymphocytes genetically modified to express a synthetic receptor targeting a surface antigen on the selected cells i.e. tumor cell or B-cell.. Most clinically approved CAR T-cell products target CD19\, which is widely expressed on B-cell lymphomas and leukemias. Following ex vivo genetic modification and expansion\, the cells are reinfused into the patient to mediate targeted anti-tumor activity. \n\n\n\nClinical studies have demonstrated remarkable efficacy\, with many patients achieving durable remissions and potential cures despite having exhausted conventional treatment options. Uppsala University Hospital pioneered CAR T-cell therapy in Europe\, initiating academic studies in 2014 and contributing to the implementation of CAR T-cells as standard of care in Sweden since 2019. Current research focuses on improving efficacy while reducing treatment-related toxicities\, including cytokine release syndrome\, neurotoxicity\, and immune effector cell-associated hematotoxicity. \n\n\n\nA novel academic phase I study\, CARMA\, evaluates an in-house produced CD20-targeting CAR T-cell armed with a neutrophil activating protein (NAP) derived from Helicobacter pylori. Preliminary results are highly encouraging\, with complete metabolic remissions observed in many evaluable patients and only mild adverse effects. Ongoing translational studies aim to identify biomarkers of response and resistance\, ultimately supporting the development of safer and more effective CAR T-cell therapies. \n\n\n\n\nProf. Göran Jönsson\nLund University \n\n\n\nTitle: Exploring the role of the anti-tumor immune response in tumor initiation and therapy response in melanoma \n\n\n\nBiosketch: Göran Jönsson is a professor in molecular oncology at Lund University. His research has for many years been based on strong collaboration between basic- and clinician scientists in truly translational projects. Considering this and his background in state-of-the art genomic technologies and applying that on human melanoma tissue puts him in a perfect position to conduct research that will generate groundbreaking findings. This is further substantiated by the group’s publication in Nature (2020). Göran is a faculty member of ESMO (European Society of Medical Oncology) and have an extensive international network. He is frequently invited to large international meetings and acts as a reviewer to several funding agencies and high-impact journals such as Nature. Göran has also been the recipient of Young and Senior Investigator Awards from the Swedish Cancer Society and more recently was awarded with the Göran Gustafsson prize in medicine 2022 from the Royal Swedish Academy of Sciences and Cancer Researcher of the year (2023) from the Swedish Cancer Society. \n\n\n\nAbstract: \n\n\n\n \n\n\n\n\nProf. Iñaki Martin-Subero\nICREA Research Professor at IDIBAPS\, Barcelona\, Spain \n\n\n\nTitle: Epigenetic memory in chronic lymphocytic leukemia: decoding the past predicts the future \n\n\n\nBiosketch: In 2001\, I obtained my PhD in Biochemistry from the University of Navarra on genetics of lymphoid neoplasms under the supervision of Prof. Maria J Calasanz and co-supervision of Prof. Reiner Siebert from the Christian-Albrechts University of Kiel. After that\, I continued my studies on lymphoma genetics as postdoctoral fellow with Prof. Siebert. In 2005\, I became interested in the field of epigenomics and in 2009 I came back to Spain. After a short stay at the IDIBELL\, I went to the UB/IDIBAPS to start my career as independent researcher embedded in the group of Prof. Elias Campo. In 2016\, I was appointed Junior Leader of the Biomedical Epigenomics group at the IDIBAPS and from November 2018 I am ICREA Research Professor at the IDIBAPS. I also have an appointment as associate professor at the UB. Our group is interested in the role of epigenetics in the origin\, evolution and clinical manifestations of lymphoid tumors. \n\n\n\nAbstract: Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in the Western world. Its clinical behavior is extremely variable\, ranging from cases that regress spontaneously without treatment to cases that transform to aggressive lymphomas with short median survival\, a condition called Richter transformation. Such clinical heterogeneity is partially associated with genetic features\, although predicting the future clinical evolution of CLL patients is still challenging. During the last decade\, we have also been investigating the CLL epigenome. We have observed that CLL cells carry DNA methylation imprints of their cellular origin allowing the distinction of three clinical subtypes derived from B cells at different maturation stages. Additionally\, DNA methylation changes in late replicating regions accumulate as cancer cells divide\, allowing the development of a mitotic clock that is able to trace the proliferative history of cancer cells. Furthermore\, using CpG sites with fluctuating methylation\, it is now possible to decode the evolutionary dynamics of CLL development. These aspects of epigenetic memory are strongly associated with disease progression. Studying the transition from CLL to Richter transformation from a multiomics perspective\, we detected that progression was accompanied by the expected increase in complexity of several molecular layers. However\, a detailed genomics and transcriptomics examination at the single cell level revealed that the Richter-associated subclone was present in minute amounts already at the time of diagnosis\, up to two decades before transformation. Overall\, these studies and additional unpublished data presented in the meeting\, indicate that molecular imprints of the past are useful markers to estimate the future clinical behavior of the patients. \n\n\n\n\nProf. Thoas Fioretos\nLund University \n\n\n\nTitle: From Genomic Discoveries to Better Diagnostics and Therapies in Acute Leukemia \n\n\n\nBiosketch: Thoas Fioretos\, MD\, PhD\, is Professor of Clinical Genetics at Lund University and Senior Consultant at Skåne University Hospital. His research focuses on the molecular basis of acute leukemia and its translation into improved diagnostics and targeted therapies. His group applies genomic and single-cell approaches to define cell states\, stem-cell properties\, immune-evasion mechanisms and cell-surface targets. The group was among the first to establish IL1RAP as a therapeutic target on leukemia stem cells and recently identified SLAMF6 as an immune checkpoint in acute myeloid leukemia. These discoveries have supported antibody-based therapies\, including an investigator-initiated trial evaluating an IL1RAP-targeting antibody in AML and high-risk MDS at MD Anderson Cancer Center. Fioretos is a Wallenberg Clinical Scholar\, Platform Scientific Director of Clinical Genomics Lund at SciLifeLab and a founding member of Genomic Medicine Sweden. He is a member of the Royal Swedish Academy of Sciences and currently chairs its Class for Medical Sciences. \n\n\n\nAbstract: Acute leukemias are genetically and phenotypically heterogeneous diseases in which molecular characterization has become increasingly important for diagnosis\, risk stratification\, and treatment. Over the past decade\, advances in sequencing technologies have transformed our ability to characterize these diseases and have created new opportunities to translate genomic discoveries into clinical practice. \n\n\n\nIn Sweden\, the SciLifeLab Clinical Genomics platform\, together with Genomic Medicine Sweden (GMS)\, has established a national framework for translating next-generation sequencing into routine healthcare. In hematological malignancies\, these efforts have enabled harmonized genomic diagnostics across the country\, including implementation of broad gene-panel sequencing and the development and evaluation of whole-genome and transcriptome sequencing as comprehensive diagnostic approaches for acute leukemia. \n\n\n\nGenomic technologies are also providing new opportunities for therapeutic discovery. By integrating bulk and single-cell genomic approaches with functional studies\, our research aims to identify vulnerabilities of leukemic stem cells and mechanisms by which they evade immune surveillance. One example is IL1RAP\, initially identified through genomic studies as a cell-surface marker and therapeutic target on leukemic stem cells. This discovery has progressed to antibody-based therapy and is currently being evaluated clinically in patients with acute myeloid leukemia and high-risk myelodysplastic syndromes. More recently\, multimodal single-cell studies identified SLAMF6 as an immune checkpoint expressed on leukemic stem cells\, providing a potential strategy for restoring T-cell recognition and killing of AML cells. \n\n\n\nTogether\, these examples illustrate a translational continuum in which genomic technologies not only improve the precision and equity of leukemia diagnostics but also uncover disease mechanisms and therapeutic targets. The combination of national genomic infrastructure\, deeply characterized patient cohorts\, single-cell technologies\, and clinical translation provides a powerful framework for moving discoveries from leukemia genomes toward improved diagnostics and new therapies. \n\n\n\n \n\n\n\n \n\n\n\n\nProgram\n\n\n\n08:30Registration and poster hangingPlease leave large bags and outerwear in the staffed Cloakroom09:00Doors open. Be seated at 09:1509:15Welcome by SciLifeLab Director Jan Ellenberg09:35Session 1: Immune Niches in CancerModerator: Anna Dimberg\, Camilla EngblomA vascular perspective on immunity in cancer and inflammationGabriele Bergers\, VIB-KU Leuven Center for Cancer Biology\, BelgiumExploring the role of the anti-tumor immune response in tumor initiation and therapy response in melanomaGöran Jönsson\, Lund University\, SwedenFlash Talks:Mast Cell Density is Associated with Opposing Survival Outcomes in Lung Adenocarcinoma and Squamous Cell Carcinoma: Potential Crosstalk with M2-like MacrophagesMariana Habas Sánches\, Uppsala UniversityTree and space-aware optimal transport for single-cell and spatial transcriptomics data integrationPedro Miguel Falé Ferreira\, KTH10:45Coffee and Poster session (odd numbers)11:25Session 2: Tumor Microenvironment and Clinical TranslationModerator: Carina StrellFibroblast – Immune niches in health and diseaseAri Molofsky\, University of California\, San Francisco (UCSF)\, USEvoking Tumor Immunity in Immune-Resistant CancersAngelica Loskog\, Uppsala University\, Sweden and Lokon PharmaCAR T-cells: a powerful new immunotherapyGunilla Enblad\, Uppsala University and Uppsala University Hospital\, Sweden12:45Lunch13:45Session 3: Precision OncologyModerator: Jessica Nordlund & Panagiotis BaliakasEpigenetic memory in chronic lymphocytic leukemia: decoding the past predicts the futureIñaki Martin-Subero\, IDIBAPS\, SpainFrom Genomic Discoveries to Better Diagnostics and Therapies in Acute LeukemiaThoas Fioretos\, Lund University\, Sweden14:45Roundtable discussion: What is needed to translate Swedish cancer discoveries into clinical implementation?Moderator: Thuy TranPanelists: Gunilla Enblad\, Thoas Fioretos\, Maréne Landström\, Angelica Loskog\, Kristian Sandberg.Flash Talks:Myofibroblastic cancer-associated fibroblasts are associated with glioblastoma progressionSebastian Braun\, Lund University Cancer Centre (LUCC)Targeting cancer-intrinsic neddylation activates cGAS/STING and overcomes acquired resistance to PD-1 blockadeMarta Rúbies Bedós\, Uppsala University15:15Coffee and Poster session (even numbers)15:55Session 4: Tumor Ecosystems and Spatial BiologyModerator: Aristidis MoustakasHighly multiplexed imaging of tissues with subcellular resolution by imaging mass cytometryBernd Bodenmiller\, University of Zurich and ETH Zurich\, SwitzerlandNOX2-derived ROS as drivers of metastatic progressionAnna Martner\, University of Gothenburg\, Sweden16:50Best Poster Award and Closing wordMia Phillipson\, Co-Director\, SciLifeLabPoster Jury of SciLifeLab and DDLS Fellows17:00Meet-the-speaker and network mingle with snacks and beverages18:15End of SciLifeLab Science Summit\n\n\n\nProgram Science Summit 2026Download\n\n\n\nPoster session\n\n\n\nEveryone\, especially junior (PhD and postdoc) researchers are encouraged to participate with poster presentations and have the opportunity to win the Best Poster Award. \n\n\n\nPosters will be on display all day\, and you are highly encouraged to view them during the coffee and lunch break. To meet the presenters and ask questions\, please note the scheduled Author Stand-By Times based on poster numbers: \n\n\n\nOdd-Numbered Posters: Presenters will stand by their posters during the forenoon coffee break. \n\n\n\nEven-Numbered Posters: Presenters will stand by their posters during the afternoon coffee break. \n\n\n\nScience Summit 2026 Poster abstract book finalDownload\n\n\n\nDetails about the Poster session\nPoster Presentation Guidelines \n\n\n\nPoster Format \n\n\n\nThe poster boards are 103 cm wide and 143 cm high. \n\n\n\nMount your poster \n\n\n\nThe venue will be open from 8:30 AM. Please proceed to the 6th floor and hang your poster at your designated number. A numbered poster list will be provided closer to the event date. \n\n\n\nPoster sessions \n\n\n\nPoster Session I: During the morning coffee break\, presenters of posters with odd numbers (1\, 3\, 5\, 7…) should be present by their posters. \n\n\n\nPoster Session II: During the afternoon break\, presenters of posters with even numbers (2\, 4\, 6\, 8…) should be present by their posters. \n\n\n\nBest Poster Award \n\n\n\nAll poster presenters should attend the Best Poster Award ceremony at the end of the conference\, where the Best Poster Award will be announced. The Poster Jury will read the abstracts and evaluate the posters throughout the day based on (a) Quality of Science (b) Design (c) Capacity to explain the work. The Poster Jury will select the 2026 Science Summit Best Poster and award the winner a 5\,000 SEK Travel Grant (conditions apply). \n\n\n\nFlash Talks (5-min research pitch) selected from Abstracts. \n\n\n\nThe abstracts will be published on the event website and used to select Flash Talks (5-min research pitch).  \n\n\n\nDismount of posters \n\n\n\nPlease remove your poster immediately after the last poster session (at 15:55). Poster screens will be collected at 5:00 PM\, and any remaining posters will be discarded. \n\n\n\n\nBest Poster Award\n\n\n\nThe Poster jury\, consisting of SciLifeLab Fellows\, will nominate the Science Summit 2026 Best Poster and award the winner a 5 000 SEK Travel Grant. \n\n\n\n\n\n\n\nPractical information\n\n\n\nTravel to Uppsala\n\n\n\nThe Venue\, Uppsala Konsert & Kongress (UKK) is next to the Train station. MAP here! Travel centres\, bus stops\, parking and hotels are all located within walking distance from Uppsala Konsert & Kongress. Several train and bus lines connect Uppsala to the rest of the country and the region\, and Arlanda Airport is only 18 minutes by train\, Stockholm Central station is approx. 30 minutes by train. \n\n\n\nUppland public transport (UL) timetables and information: www.ul.seSJ timestables and information: www.sj.se \n\n\n\nGood to know\, travelling to Uppsala. \n\n\n\nParking\n\n\n\nThe nearest parking garage is Centralgaraget. There is also parking available in Kvarnens parking garage\, Svava\, S:t Per Gallerians garage\, Österplan\, and several other locations in central Uppsala. For more information about parking in the area\, please visit Uppsala Parkering. \n\n\n\nHotels in Uppsala\n\n\n\nFind suggestions for accommodation in Uppsala here \n\n\n\n\nImproved event experience: Introducing the Lyyti Event app \n\n\n\nThis event uses Lyyti for registration. Lyyti has launched the Lyyti Event app\, where you can find your Lyyti registration\, confirmation\, and ticket. You can also edit your information until the registration deadline. \n\n\n\nTo get started\, download “Lyyti Event” and sign up with the same email address you normally use for event registrations. The app only displays events associated with the email address used to create your account. \n\n\n\nIf you register for events using multiple email addresses\, you can link several email addresses to your app account. For the best experience\, please use one consistent email address for all Lyyti registrations. We hope this new functionality makes it easier for you to manage your participation. \n\n\n\n\nYou may also be interested in:\n\n\n\n\nThe PROMISE Initiative: Accelerating Cancer Innovation
URL:https://www.scilifelab.se/event/scilifelab-science-summit-2/
LOCATION:Uppsala Konsert & Kongress (UKK)\, Vaksala torg 1\, Uppsala\, 753 31\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2025/12/Hemsidan_feature-image-kopiera.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260917T084500
DTEND;TZID=Europe/Stockholm:20260917T170000
DTSTAMP:20260916T111826Z
CREATED:20260615T092942Z
LAST-MODIFIED:20260916T111826Z
UID:10001847-1789634700-1789664400@www.scilifelab.se
SUMMARY:Campus Solna Science Talks 2026
DESCRIPTION:Warmly welcome to the seventh Campus Solna Science Talk – a meeting for everyone in the community to learn more about ongoing research and activities at SciLifeLab’s Campus Solna\, which aims to bring the community together\, inspire exchange and new collaborations. \n\n\n\nResearch presentations will be given by group leaders and junior researchers (selected with consideration for balance in topics\, presenters’ career stages\, and affiliations) as part of four plenary sessions that will be mixed with panel discussions. During breaks and lunch there will be ample time for networking and poster sessions. \n\n\n\nWe invite all Campus Solna research groups to be represented with at least 1 poster (and maximum 3). Furthermore\, we want to encourage all infrastructure units\, support functions (IT\, OO\, Site support) and committees (DEI\, Public Engagement\, CSI and the PhD&Postdoc Council) to partake with posters! \n\n\n\nSeats are limited\, register today to secure your spot! \n\n\n\nRegistration\n\n\n\n \n\n\n\nProgram\n\n\n\nProgram CS Science Talks 2026Download\n\n\n\nPoster list\nPoster session A and B names and titles (1)_v2Download\n\n\n\n\nScientific committee\nHjalmar Brismar \n\n\n\nErik Benson \n\n\n\nMagda Bienko \n\n\n\nAnniina Vihervaara \n\n\n\nPatrick Bryant \n\n\n\nGisele Miranda \n\n\n\nAbishek Arora \n\n\n\nBruno Stojcic \n\n\n\nDisa Larsson Hammarlöf\, OO-support \n\n\n\nIsolde Palombo\, OO-support
URL:https://www.scilifelab.se/event/campus-solna-science-talks-2026/
LOCATION:Life City\, Solnavägen 3H\, Stockholm\, 113 64
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/Fasad-SciLifeLab-Solna-2022-2-1-scaled.jpeg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260916T091500
DTEND;TZID=Europe/Stockholm:20260916T103000
DTSTAMP:20260914T080814Z
CREATED:20260908T120519Z
LAST-MODIFIED:20260914T080814Z
UID:10001890-1789550100-1789554600@www.scilifelab.se
SUMMARY:Molecule-scale resolution and dynamics in fluorescence microscopy
DESCRIPTION:Guest Lecture by: Prof. Dr. Stefan W. HellDirector\, Max Planck Institute for Multidisciplinary Sciences\, GöttingenDirector\, Max Planck Institute for Medical Research\, HeidelbergNobel Laureate in Chemistry (2014) \n\n\n\n \n\n\n\nHost: Jan Ellenberg\, SciLifeLab Director \n\n\n\nSpace is limited\, please sign up to secure your seat. Venue: ”Air&Fire”\, SciLifeLab Campus Solna\, Tomtebodavägen 23A. [Or live streamed via Zoom – sign up to receive link] \n\n\n\nRegistration\n\n\n\nBiography\n\n\n\n \n\n\n\nStefan Hell is a director at both the Max Planck Institute for Multidisciplinary Sciences in Göttingen and the Max Planck Institute for Medical Research in Heidelberg\, Germany. \n\n\n\nHe is credited with having conceived\, validated and applied the first viable concept for overcoming Abbe’s diffraction-limited resolution barrier in a light-focusing fluorescence microscope. For this accomplishment he has received numerous awards\, including the 2014 Kavli Prize in Nanoscience and the Nobel Prize in Chemistry. \n\n\n\nStefan Hell received his doctorate (1990) in physics from the University of Heidelberg. From 1991 to 1993 he worked at the European Molecular Biology Laboratory\, followed by stays as a senior researcher at the University of Turku\, Finland\, between 1993 and 1996\, and as a visiting scientist at the University of Oxford\, England\, in 1994. In 1997 he was appointed to the MPI for Biophysical Chemistry (named Max Planck Institute for Multidisciplinary Sciences since 2022) in Göttingen as a group leader\, and was promoted to director in 2002. From 2003 to 2017 he also led a research group at the German Cancer Research Center (DKFZ). Hell holds honorary professorships in physics at the Universities of Heidelberg and Göttingen. \n\n\n\nCopyright: MPImR
URL:https://www.scilifelab.se/event/molecular-scale-resolution-and-dynamics-in-fluorescence-microscopy/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260909T090000
DTEND;TZID=Europe/Stockholm:20260910T133000
DTSTAMP:20260907T092435Z
CREATED:20260513T143630Z
LAST-MODIFIED:20260907T092435Z
UID:10001825-1788944400-1789047000@www.scilifelab.se
SUMMARY:PLP Network Meeting 2026
DESCRIPTION:The Pandemic Laboratory Preparedness (PLP) Network Meeting brings our community together to strengthen connections across the PLP network\, spark new collaborations\, and identify exciting opportunities for future development and impact. \n\n\n\nThrough inspiring invited talks\, an engaging poster session\, interactive group discussions\, and plenty of social activities\, the meeting will create a dynamic forum for exchanging ideas\, sharing expertise\, and building the partnerships that will shape future pandemic preparedness efforts \n\n\n\nInvitation only \n\n\n\nContact. Alice Sollazzo\, alice.sollazzo@scilifelab.uu.se \n\n\n\n\n\n\n\nProgram\n\n\n\nProgram PLP Network Meeting 2026Download\n\n\n\nPoster List\n\n\n\nPoster List – PLP Retreat 2026Download\n\n\n\nBusses\n\n\n\nTo Nova Park – September 9FromDepartureUppsala (BMC)\, Husargatan 3\, entrance C1109:00Stockholm\, Cityterminalen (via Campus Solna)08:30Arlanda\, T409:00From Nova Park – September 10DepartureToUppsala (BMC)\, Husargatan 3\, entrance C1113:30Stockholm\, Cityterminalen (via Campus Solna)13:30Arlanda\, T413:30\n\n\n\n\n\n\n\nScientific Committee:\n\n\n\n\nStaffan Svärd\, UU\n\n\n\nJessica Alm\, KI\n\n\n\nClaudia Fredolini\, KTH\n\n\n\nTobias Allander\, KI\n\n\n\nMattias Forsell\, UmU\n\n\n\nMahmoud Naguib\, UU
URL:https://www.scilifelab.se/event/plp-network-meeting-2026/
LOCATION:Nova Park\, Gredelbyvägen 138\, 741 71\, Knivsta
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260907T153000
DTEND;TZID=Europe/Stockholm:20260907T163000
DTSTAMP:20260901T122823Z
CREATED:20260901T121718Z
LAST-MODIFIED:20260901T122823Z
UID:10001882-1788795000-1788798600@www.scilifelab.se
SUMMARY:Phase separation in cell physiology and disease
DESCRIPTION:Speaker: Anthony Hyman\, Director General EMBLHost: Jan Ellenberg\, Director SciLifeLab \n\n\n\nCells organize many of their biochemical reactions by formation and dissolution of non-membrane-bound compartments. Recent experiments show that one common mechanism for such biochemical organization is phase separation of disordered proteins to form compartments with liquid properties. \n\n\n\nThese compartments can subsequently harden to form compartments with new material properties such as gels and glasses. These compartments can be described by principles elucidated from condensed-matter physics and are therefore termed biomolecular condensates. I will discuss potential roles of condensates in organization and robustness of cellular biochemistry and how they fail in neurodegenerative disease\, using aggregation of TDP-43 in ALS as a model. \n\n\n\nregistration\n\n\n\nBio \n\n\n\nThe Hyman lab studies how phase separation impacts the formation of membraneless compartmentalisation of macromolecules inside living cells. Stemming from our work on C.elegans in 2009 (Brangwynne et al. 2009)\, observations over the last decade have shown that many non-membrane compartments have liquid-like properties (Banani et al. 2017). The liquid-like nature of condensates is ascertained using microscopy in cells by observing fusion events\, round shape\, rapid diffusion of components\, and a predictable response to changes in thermodynamic parameters such as temperature. Phase separation phenomena can be used to describe the formation of P granules (Brangwynne et al. 2009)\, nucleoli (Brangwynne et al. 2011)\, stress granules and centrosomes (Brangwynne et al. 2009) and estimates suggest that at least 30% of proteins in the nucleus are in such compartments (Thul et al. 2017). To capture the role of soft matter physics in describing these compartments\, we have termed them biomolecular condensates (Banani et al. 2017).  \n\n\n\nFor more details visit: https://hymanlab.org/hyman_lab/research-overview/
URL:https://www.scilifelab.se/event/phase-separation-in-cell-physiology-and-disease/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260616T110000
DTEND;TZID=Europe/Stockholm:20260616T120000
DTSTAMP:20260604T153824Z
CREATED:20260603T073920Z
LAST-MODIFIED:20260604T153824Z
UID:10001842-1781607600-1781611200@www.scilifelab.se
SUMMARY:Cryo-electron microscopy as a discovery tool in sperm biology
DESCRIPTION:Speaker: Tzviya Zeev-Ben-Mordehai\, Utrecht University \n\n\n\nAbstract\n\n\n\nCryo-EM single-particle analysis (SPA) approaches typically entail overexpression and purification of the target complex. For that\, prior knowledge of the composition of the complex of interest is required. In the highly specialised sperm cell\, the molecular composition is often not known. During my talk\, I will show how we expand the range of samples attainable for SPA towards more native samples\, specifically towards complex macromolecular assemblies that cannot be reconstituted\, and show how SPA is used as a discovery tool in sperm biology. \n\n\n\nBiography\n\n\n\nAn expert in reproductive structural biology. Zeev-Ben-Mordehai received her PhD from the Weizmann Institute of Science in 2008. In 2015 she established her group in the Division of Structural Biology of Oxford University. Since 2017 her group is part of Bijvoet Centre for Biomolecular Research of Utrecht University. Her group developed the first cryo-ET workflow for mammalian sperm\, enabling molecularresolution imaging of flagellar ultrastructure across species. Her landmark studies have revealed the multi-scale architecture of mammalian sperm flagella (EMBO J 2021)\, structural specialisations of the sperm tail (Cell 2023)\, structural diversity of axonemes across mammalian motile cilia (Nature 2025)\, and in-cell structures at the mitochondria– cytoskeleton interface in sperm (PNAS 2021). Zeev-Ben-Mordehai is a recipient of a Wellcome Trust and The Royal Society Sir Henry Dale Fellowship (2015)\, NWO START-UP (2018)\, ERC-consolidator grant (2023) and an NWO-Vici grant (2025). \n\n\n\nHost; Luca Jovine luca.jovine@ki.se
URL:https://www.scilifelab.se/event/cryo-electron-microscopy-as-a-discovery-tool-in-sperm-biology/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260603T080000
DTEND;TZID=Europe/Stockholm:20260603T170000
DTSTAMP:20260603T110136Z
CREATED:20260112T103449Z
LAST-MODIFIED:20260603T110136Z
UID:10001701-1780473600-1780506000@www.scilifelab.se
SUMMARY:Cell Biology at Scale 2026
DESCRIPTION:The Cell Biology at Scale (CB@S) meeting is co-hosted by SciLifeLab\, the national research infrastructure for life science in Sweden\, and Biohub. This event aims to bring together researchers working at the interface of cell biology\, imaging\, functional genomics\, computational biology\, and artificial intelligence. \n\n\n\nRecent advances in multiplexed molecular profiling\, high-resolution imaging\, perturbation technologies\, and AI-driven modeling are changing how we study cells. Conducting cell biology at scale is not simply about increasing throughput. It represents a shift in how experiments are designed\, how data are integrated\, and how biological questions are formulated across molecular\, cellular\, and organismal levels. \n\n\n\nCB@S 2026\, a one-day symposium\, will focus on forward-looking perspectives: \n\n\n\n\nHow do we integrate multimodal cellular data?\n\n\n\nHow can modeling and AI help build predictive\, cell-scale theoretical frameworks?\n\n\n\nWhat experimental and computational strategies are still missing?\n\n\n\n\nThe symposium will be accessible both on site and via live stream. \n\n\n\nThe annual CB@S meetings started four years ago\, and so far\, all have taken place in the United States. Now for the first time\, the meeting will be hosted in Europe. Stockholm is an established international center for interdisciplinary life science research\, with strong environments in cell biology\, data-driven biology\, and technology development. \n\n\n\nThis event is kindly supported by Chan Zuckerberg Initiative and Knut and Alice Wallenberg Foundation. \n\n\n\nInvited Speakers \n\n\n\nAlexander van Oudenaarden\, Hubrecht InstituteAubrey Weigel\, Howard Hughes Medical InstituteFlorian Jug\, Human TechnopoleJan Funke\, Human TechnopoleJohann Wenckstern\, EPFLJohannes Schöneberg\, UCSDLukas Kapitein\, Utrecht UniversityMagda Bienko\, SciLifeLab\, Karolinska Institutet / Human TechnopoleRalf Jungmann\, Max Planck Institute of BiochemistrySuliana Manley\, EPFL \n\n\n\nRegistration \n\n\n\nRegistration for on-site participation is now closed. Registration for on-line participation remains open. \n\n\n\nregistration for on-line participation\n\n\n\nProgram \n\n\n\nProgram and sessions are preliminary and subject to change \n\n\n\nTimeActivity08:00Doors open\, registration\, coffee09:00Welcome remarks (SciLifeLab & Biohub)Jan Ellenberg\, Manuel Leonetti & Paul BlaineySession I – Molecular Mapping at ScaleModerators: Johan Elf + Paul Blainey09:20Novel sequencing tools to monitor translation in individual cellsAlexander van Oudenaarden09:40DNA-associated intronic RNAs form introsomes that shape genome architecture in neurons Magda Bienko10:00Short presentationsIntegrating spatial multi-omics to reveal inflammatory and regulatory signalling niches in the lungAlexandra FirsovaFrom Genome to Drug Targets: A Computational Pipeline for Setaria digitataBará AdiHow to achieve high throughput and correlative biophysical\, physiological and multiomic dataErdinc Sezgin10:15Session Wrap up10:20Coffee BreakSession II – Cellular Organization & DynamicsModerator: Jan Ellenberg10:504D Cell Biology: Drug Discovery using Advanced Microscopy\, Organoids\, Digital Twins\, and AIJohannes Schöneberg11:10Using light to dissect and direct cellular organization and dynamicsLukas Kapitein11:30Mapping Cells at Scale: Sharing Data and Workflows for Tissue-Scale vEMAubrey Weigel11:50Tunable Three-Photon-Activatable Cyclooctynes for Wavelength-Selective Labeling of Nascent RNA and Proteins in CellsDaniel Fürth12:00Short presentationsThe Fourth Dimension: Probing Developmental and Evolutionary Time in Spatial OmicsMarco GrilloStitch-seq: A Facile and High-Throughput Perturbation Sequencing MethodFrances KeerMINFLUX – SRS – TPE FLIM imaging of bacteria and their targeted host cellsChinmaya Venugopal Srambickal12:15Session Wrap-up12:20Lunch and Poster sessionSession III – From imaging to modelsModerator: Manuel Leonetti13:30From DNA Nanotechnology to Biomedical Insight: Towards Single-Molecule Spatial OmicsRalf Jungmann13:50Smart microscopy reveals patterns in the mitochondrial life cycleSuliana Manley14:10Live-cell nanoscopy empowered by computationIlaria Testa14:20Short PresentationsScaling Cell Biology with Smart Microscopy: Adaptive Workflows as a ServiceRafael CamachoAgentic-J: An All-Round AI Agent for Cell Biologists Analyzing Microscopy Images from Exploration to PublicationsJianxu ChenFrom Learning to Generating Representations: Constructing a Visual-based World Model for Virtual Cells at Meso-scaleGaole Dai14:35Discussion & Session Wrap-up14:40Coffee BreakSession IV – Outlook: Building Predictive Cell BiologyModerators: Sanja Vickovic + Jason Swedlow15:10AI as a Trusted Partner for Scientific Discovery Across Biological ScalesFlorian Jug15:30Mechanistic Models of MorphogenesisJan Funke15:50Virtual Patient Labs: AI-Driven Simulation and Diagnostics for Precision OncologyJohann Wenckstern\, EPFL16:10Short PresentationsCells as Single-Molecule Protein Proximity NetworksFilip KarlssonLive-cell transcriptomics with engineered virus-like particlesMohamad Najia16:20Imaging to Build a World Model of BiologyManuel Leonetti16:30Alpha CellJan Ellenberg16:40Panel discussionAudience Q&A17:10Conference Wrap up – Thank you17:15End of MeetingPost-symposium mingle\n\n\n\nPoster Session\n\n\n\nCBAS – All Submitted Abstracts.docxDownload\n\n\n\nScientific Committee \n\n\n\nPaul BlaineyIain CheesemanJohan ElfJan EllenbergManuel LeonettiCarolina WählbyLucas PelkmansJason SwedlowSanja Vickovic
URL:https://www.scilifelab.se/event/cell-biology-at-scale-2026/
LOCATION:Life City\, Solnavägen 3H\, Stockholm\, 113 64
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2026/01/CBAS_Social_Card_Co-Brand_BLK_1276x720.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260526T090000
DTEND;TZID=Europe/Stockholm:20260526T170000
DTSTAMP:20260508T091411Z
CREATED:20260213T094027Z
LAST-MODIFIED:20260508T091411Z
UID:10001754-1779786000-1779814800@www.scilifelab.se
SUMMARY:Challenges in GPCR Drug Discovery
DESCRIPTION:G protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome and one of the key targets for therapeutic approaches across many disease areas. However\, only around 25% of the druggable GPCRs have been tapped into. This presents a significant opportunity to develop novel medicines with high therapeutic impact for the GPCR class in numerous indications. \n\n\n\nThe Challenges in GPCR drug discovery workshop is co-organized by Gothenburg University\, Uppsala University\, and AstraZeneca to explore the latest advancements in GPCR drug discovery research. Our aim is to bring together renowned international experts from industry\, biotech\, academia and service providers to facilitate communication between scientific groups and research areas within GPCR drug discovery community. The workshop focusses on lead-generation aspects such as\, computational approaches\, structural biology and pharmacology in early drug discovery of GPCRs. We believe this will lead to uncovering common challenges and finding new innovative approaches to drug discovery for GPCRs\, and further strengthen the GPCR community in the Nordics. \n\n\n\nThe workshop has a maximum of 90 attendants generating an informal atmosphere encouraging discussions\, networking and information exchange. Participants are encouraged to submit poster abstracts. Registration deadline is 27th of April. Due to the limited number of seats\, with over-subscription the organizing committee will maintain the right to select participants on the basis of fit to the program\, participants with a poster contribution will be prioritized\, otherwise selections in order of registration. \n\n\n\nRegistration\n\n\n\nVenue\n\n\n\nAstraZeneca Gothenburg\, Pepparedsleden 1\, 431 53\, MölndalParticipants are welcomed to report at the reception at the main entrance (KC) \n\n\n\nConfirmed Speakers\n\n\n\n\nMartin Gustavsson\, Copenhagen University\n\n\n\nElisabeth Rexen Ulven\, Copenhagen University\n\n\n\nAlexander Hauser\, Copenhagen University\n\n\n\nJanosch Ehrenmann\, LeadXpro\n\n\n\nAndreas Kiessling\, Cube-Biotech\n\n\n\nMadan Babu\, St. Jude Children’s Research Hospital\n\n\n\nGunnar Schulte\, Karolinska Institutet\n\n\n\nTore Bengtsson\, Atrogi\n\n\n\n\nOrganizing committee\n\n\n\n\nLinda Johansson\, Gothenburg University\n\n\n\nJens Carlsson\, Uppsala University\n\n\n\nArjan Snijder\, AstraZeneca\n\n\n\n\nThis workshop is sponsored by: Cube Biotech \n\n\n\nFlyer \n\n\n\nChallenges in GPCR drug discovery workshop 2026Download
URL:https://www.scilifelab.se/event/challenges-in-gpcr-drug-discovery/
LOCATION:AstraZeneca (KC Reception)\, Pepparedsleden 1\, Mölndal\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2026/02/gprotein.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260505T090000
DTEND;TZID=Europe/Stockholm:20260505T100000
DTSTAMP:20260319T113713Z
CREATED:20260319T113141Z
LAST-MODIFIED:20260319T113713Z
UID:10001777-1777971600-1777975200@www.scilifelab.se
SUMMARY:Live-Cell Super-Resolution Microscopy: Technological Progress\, Hybrid Methodologies\, and Applications in Omics
DESCRIPTION:Liangyi Chen\, New Cornerstone Investigator\, Institute of Molecular Medicine\, National Biomedical Imaging Center\, Peking University\, China. \n\n\n\nHost: Jan Ellenberg\, SciLifeLab \n\n\n\nAbstract\n\n\n\nIn this talk\, I will present our decade-long efforts to advance state-of-the-art live-cell super-resolution microscopy. By introducing spatiotemporal Hessian regularization\, we developed Hessian Structured Illumination Microscopy (Hessian-SIM)\, which substantially reduces phototoxicity and enables real-time\, long-term imaging of dynamic structures such as mitochondrial cristae and insulin vesicle fusion pores in living cells. We next engineered a dual-modality fluorescence/label-free microscope for panoramic super-resolution imaging\, facilitating the discovery of novel organelles. Our 4Pi-SIM and 3D multiplane SIM (3D-MP-SIM) techniques deliver ~100-nm isotropic resolution while achieving a tenfold increase in volumetric imaging speed for live cells.  \n\n\n\nFurthermore\, we introduced a universal sparse deconvolution algorithm that overcomes the optical Rayleigh diffraction limit. When applied to structured illumination\, it enables 60-nm resolution at 564 Hz for sustained live-cell imaging and enhances resolution in multiphoton and light-sheet microscopy in vivo. Finally\, I will discuss our recent developments in a SIM-FLIM system and the integration of live-cell super-resolution SIM imaging with single-cell RNA sequencing to bridge nanoscale dynamics with transcriptomic profiles.
URL:https://www.scilifelab.se/event/live-cell-super-resolution-microscopy-technological-progress-hybrid-methodologies-and-applications-in-omics/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260422T140000
DTEND;TZID=Europe/Stockholm:20260422T160000
DTSTAMP:20260331T125134Z
CREATED:20260330T141954Z
LAST-MODIFIED:20260331T125134Z
UID:10001793-1776866400-1776873600@www.scilifelab.se
SUMMARY:Digital Townhall meeting about the Beta building of Campus Solna
DESCRIPTION:Welcome to a townhall meeting for the SciLifeLab community to hear more about the plans of Campus Solna expansion to include the Beta building\, and to learn what this means for SciLifeLab from a national perspective. \n\n\n\nAgenda\n\n\n\n\nThe national perspective on Campus Solna expansion – what does this mean for SciLifeLab? Jan Ellenberg\, SciLifeLab Director\n\n\n\nThe Beta project\, Per Ljungdahl\, Campus Solna Director\n\n\n\nQ&A session\n\n\n\n\nAfter the digital meeting\, all community members present at Campus Solna on April 22nd are most welcome to join the continued dialogue about the Beta project in the Delta area/lobby. Refreshments will be served. \n\n\n\nRegister here
URL:https://www.scilifelab.se/event/digital-townhall-meeting-about-the-beta-building-of-campus-solna/
LOCATION:Online event via Zoom
CATEGORIES:Community
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260420T090000
DTEND;TZID=Europe/Stockholm:20260420T173000
DTSTAMP:20260420T091034Z
CREATED:20260210T110215Z
LAST-MODIFIED:20260420T091034Z
UID:10001753-1776675600-1776706200@www.scilifelab.se
SUMMARY:Stockholm Single Cell and Spatial Genomics Symposium 2026
DESCRIPTION:The Stockholm Single Cell and Spatial Genomics Symposium 2026 is a national meeting dedicated to advancing single-cell and spatial genomics technologies and their application in basic\, applied\, and translational research. \n\n\n\nBuilding on the success of the 2024 symposium\, this full-day event will once again bring together leading Swedish and international researchers\, technology developers\, and industry partners. The program will feature keynote lectures\, scientific talks\, technology showcases\, and ample networking opportunities\, with a strong focus on state-of-the-art methods and innovative applications. \n\n\n\nRegistration\n\n\n\nThis event is currently fully booked \n\n\n\nBy fostering knowledge exchange and community building\, the symposium aims to accelerate the adoption of single-cell and spatial genomics approaches across Sweden and further strengthen the national research ecosystem supported by SciLifeLab and NGI. \n\n\n\nOrganizers\n\n\n\n\n\nNational Genomics Infrastructure  \n\n\n\n\nNational Genomics Infrastructure (NGI)\n\n\n\n\n \n\n\n\n\n\nIn Situ Sequencing \n\n\n\n\nIn Situ Sequencing\n\n\n\n\n\n\n \n\n\n\nProgram\n\n\n\nAgenda.SCSG_2026 (1)Download
URL:https://www.scilifelab.se/event/stockholm-single-cell-and-spatial-genomics-symposium-2026/
LOCATION:IVA Conference center\, Grev Turegatan 16\, Stockholm
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260324T150000
DTEND;TZID=Europe/Stockholm:20260324T160000
DTSTAMP:20260306T140204Z
CREATED:20260306T140203Z
LAST-MODIFIED:20260306T140204Z
UID:10001769-1774364400-1774368000@www.scilifelab.se
SUMMARY:Application of advanced imaging technology for cell-type specific neural\, neuromodulatory and astrocytic signalling in vivo
DESCRIPTION:Sofie Ährlund-Richter\, The Picower Institute for Learning and Memory\, Massachusetts Institute of Technology (MIT) \n\n\n\nTitle: Prefrontal Cortex Feedback Reshapes the Representation and Routing of Visual Information \n\n\n\nHow does the brain determine which sensory signals are behaviorally relevant\, and how are these signals routed across cortical networks? Top-down feedback from the prefrontal cortex (PFC) has long been proposed to play a central role in shaping sensory processing\, yet the circuit-level mechanisms by which distinct prefrontal pathways modulate sensory representations remain poorly understood. \n\n\n\nHere we investigate how anatomically and functionally distinct prefrontal subregions influence visual processing in primary visual cortex (VISp). Using a combination of axonal tracing\, two- photon calcium imaging\, and projection-specific chemogenetic perturbations in behaving mice\, we show that inputs from the anterior cingulate cortex (ACA) and orbitofrontal cortex (ORB) exert dissociable and context-dependent effects on visual responses. Our findings demonstrate that prefrontal feedback is not a uniform gain signal but instead operates through modular pathways that differentially shape sensory representations according to internal state and behavioral context. Building on these results\, we are developing next-generation in vivo approaches to uncover the cell-type-specific logic underlying cortical communication. By combining spectral unmixing–based two-photon imaging\, projection-defined labeling\, and targeted perturbations\, we can simultaneously image multiple\, defined VISp neuron populations distinguished by their long-range outputs. This strategy enables direct observation of how prefrontal feedback redistributes visual information across parallel cortical output channels in real time. \n\n\n\nTogether\, this work reveals how top-down control dynamically restructures sensory representations and routing in the cortex. By defining circuit principles of prefrontal modulation\, these findings provide a framework for understanding how disruptions in feedback control may contribute to altered perception and cognition in neurodevelopmental disorders. \n\n\n\nTalk 2:  \n\n\n\nIakovos Lazaridis\, McGovern Institute for Brain Research\, Massachusetts Institute of Technology (MIT) \n\n\n\nTitle: Striosomes and astrocytes shape striatal dopamine during behavioral state transitions \n\n\n\nAbstract: Basal ganglia circuits\, modulated by striatal dopamine\, support reinforcement learning\, action selection\, and behavioral flexibility. Integrating two independent lines of evidence\, we propose a framework in which striosomes set nigrostriatal output while dorsal striatal astrocytes gate local dopamine availability during behavioral state transitions. Using projection-defined circuit mapping and perturbations\, we show that striosomal D1 spiny projection neurons (SPNs) project directly to the substantia nigra pars compacta (SNpc)\, whereas striosomal D2 SPNs route indirectly via a central external globus pallidus node\, forming opponent pathways whose net influence on dopamine differs from matrix circuits. Astrocytes exhibit Ca²⁺ transients time-locked to SNpc-evoked dopamine release\, and selective astrocyte activation reduces subsequent dopamine availability without affecting spontaneous locomotion. In a probabilistic decision task\, large astrocytic Ca²⁺ events are enriched during disengagement and precede re-engagement; astrocyte signals predict upcoming state transitions and engagement more strongly than trial outcomes\, consistent with state-level regulation rather than action coding. Dopamine-dependent astrocytic adenosine release may provide a local mechanism for regulating dopamine availability while biasing D1/D2 signaling\, enabling flexible rebalancing of striatal output across behavioral states. Together\, these results link striosomal compartmental architecture to motivational control and reveal a glial gate on dopamine dynamics. \n\n\n\nHost: Iskra Pollak Dorocic
URL:https://www.scilifelab.se/event/application-of-advanced-imaging-technology-for-cell-type-specific-neural-neuromodulatory-and-astrocytic-signalling-in-vivo/
LOCATION:Room Milkyway\, Alfa Building Floor 2\, SciLifeLab Solna\, Tomtebodavägen 23\, Solna
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260323T140000
DTEND;TZID=Europe/Stockholm:20260323T150000
DTSTAMP:20260313T100358Z
CREATED:20260206T154723Z
LAST-MODIFIED:20260313T100358Z
UID:10001750-1774274400-1774278000@www.scilifelab.se
SUMMARY:Decoding Enhancer-Mediated Gene Regulation with CAGE-seq and Deep Learning
DESCRIPTION:Michiel de Hoon\, RIKEN center\, Japan \n\n\n\n\n\n\n\nAbstract\n\n\n\nPrecise regulation of gene expression is fundamental to cellular identity and behavior\, and gene dysregulation is a common feature across a wide variety of diseases.  At the molecular level\, this regulation is orchestrated by transcription factors acting on non-coding regulatory elements at promoters and distal enhancers. Genome-wide association studies have shown that disease-associated variants are enriched in enhancer elements\, and somatic mutations in these regulatory regions can contribute to diseases such as cancer. As it is often unclear how such variants influence gene expression\, connecting enhancers to their target promoters is a key step toward understanding the regulatory basis of pathogenic gene expression.Cap Analysis Gene Expression (CAGE-seq)\, originally developed at RIKEN\, provides an unbiased and quantitative genome-wide view of transcription initiation at single-nucleotide resolution. Beyond quantitating mRNAs and long non-coding RNAs\, CAGE-seq revealed widespread transcription at enhancers\, enabling their systematic identification and quantitative characterization. While traditional bioinformatics approaches have focused on genome annotation and expression analysis\, emerging neural network frameworks now enable inference of enhancer–promoter interactions directly from sequencing data. \n\n\n\nIn this presentation\, I will highlight the use of AI-based sequence-to-function frameworks that can predict transcriptional activity directly from genomic sequence. When combined with CAGE-seq\, these approaches enable the construction of context-specific regulatory maps linking enhancer activity to gene expression. Using examples from leukemia\, I will illustrate how CAGE-seq data\, analyzed using deep learning\, support a systematic interpretation of inter-patient heterogeneity in gene regulation. \n\n\n\nBiography\n\n\n\nI entered computational biology during my Ph.D. in Physics at the University of California\, Berkeley. After postdoctoral training in bioinformatics at the University of Tokyo and Columbia University\, I joined RIKEN in Yokohama\, where I became a core contributor to the FANTOM consortium\, an international effort to functionally annotate the mammalian genome. \n\n\n\nBetween 2014 and 2021\, I led the computational biology program of FANTOM6\, coordinating my research group and consortium-wide efforts to functionally annotate non-coding RNA. I am currently a tenured Senior Research Scientist at the RIKEN Center for Integrative Medical Sciences\, investigating gene regulatory mechanisms in disease\, particularly cancer. \n\n\n\nMore recently\, my research has focused on developing and applying AI-based sequence-to-function models to infer long-range gene regulatory interactions from genome and transcriptome data\, with the aim of understanding the regulatory basis of inter-patient heterogeneity in disease. \n\n\n\nHost: Pelin Sahlen pelin.akan@scilifelab.se
URL:https://www.scilifelab.se/event/decoding-enhancer-mediated-gene-regulation-with-cage-seq-and-deep-learning/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260304T100000
DTEND;TZID=Europe/Stockholm:20260304T120000
DTSTAMP:20260303T142729Z
CREATED:20260121T151158Z
LAST-MODIFIED:20260303T142729Z
UID:10001730-1772618400-1772625600@www.scilifelab.se
SUMMARY:Shaping the Future with Breakthrough Technologies in Healthcare
DESCRIPTION:Breakthrough Technologies in Molecular Life Science to Power Precision Medicine and the Future of Healthcare in Sweden \n\n\n\nYou are warmly invited to a dialogue event with the aim of bringing together healthcare\, academia\, industry\, and other stakeholders to explore a national initiative for the future of translational healthcare in Sweden. \n\n\n\nBy 2035\, Sweden has the ambition to become a world leader in translating breakthrough biotechnology and AI into patient-centered healthcare. This event will discuss the vision for an excellence cluster that integrates SciLifeLab cutting-edge molecular life science technologies with AI-driven data analysis at university hospitals across the country. At its core are joint units where clinicians\, researchers\, and technology experts work side by side to accelerate diagnosis\, personalize treatment\, and enable data-driven clinical decision support. \n\n\n\nDuring the event\, we will present the preparatory project\, outline a national collaboration between research infrastructure\, healthcare systems\, and industry. The event will also address how this initiative can strengthen Sweden’s competitiveness\, attract investment and deliver benefits for patients and society.  \n\n\n\nRegister here\n\n\n\nWe look forward to welcoming you to a forward-looking dialogue on how together we can transform healthcare through breakthrough technologies and AI. \n\n\n\nRead more about SciLifeLabs work within translation to healthcare here. \n\n\n\nProgram\n\n\n\n09:30Coffee for onsite participants – outside “Torsten Wiesel”Karolinska university Hospital\, Solnavägen 30\, Solna10:00Introduction– Jan Ellenberg\, Director SciLifeLab– Mia Phillipson\, Co-Director SciLifeLab10:10Stakeholder Reflections– Annika Östman Wernerson\, President Karolinska Institutet– Mathias Axelsson\, Managing director medical diagnostics\, Karolinska University Hospital10:20Key objectives for translation to healthcare – data\, technology & innovationValtteri Wirta\, Päivi Östling\, Per Lek10:50Examples from translational projects – When symptoms are vague\, proteins can point the way\, Mikael Åberg\, Uppsala University\, Axel Rosell\, Karolinska Institutet and Charlotte Thålin\, Karolinska Institutet– Predicting  response to immunotherapy and antibody-drug conjugate therapy using Spatial Proteomics\, Charlotte Stadler\, KTH and Anders Ullén\, Karolinska Institutet11:15Panel discussion – Q&A11:45Summary & Next steps12:00Light lunch for on-site participants
URL:https://www.scilifelab.se/event/shaping-the-future-with-breakthrough-technologies/
LOCATION:Torsten Wiesel\, Karolinska University Hospital\, Solnavägen 30\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2026/01/Translation-to-Healthcare-4-mars.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260226T000000
DTEND;TZID=Europe/Stockholm:20260226T235900
DTSTAMP:20260217T115205Z
CREATED:20260217T114852Z
LAST-MODIFIED:20260217T115205Z
UID:10001758-1772064000-1772150340@www.scilifelab.se
SUMMARY:SciLifeLab PULSE - Q&A webinar for applicants
DESCRIPTION:This is a Q&A webinar (two time options available) for general questions on the SciLifeLab PULSE application process. Find out more about the SciLifeLab PULSE postdoc program here The deadline for the 2nd SciLifeLab PULSE Call is March 16\, 2026! \n\n\n\n\n\n\n\n\n\n\n\nWebinar registration\n\n\n\n\n\nWebinar on February 26\, 2026\, at 09:00 am\, UTC+1 \n\n\n\n\n\nRegister here\n\n\n\n\n\n\n\nWebinar on February 26\, 2026\, at 16:00 pm\, UTC+1 \n\n\n\n\n\nRegister here
URL:https://www.scilifelab.se/event/scilifelab-pulse-qa-webinar-for-applicants/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2024/12/AdobeStock_519582269-scaled-1.jpeg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260130T130000
DTEND;TZID=Europe/Stockholm:20260130T143000
DTSTAMP:20260128T152020Z
CREATED:20241220T095502Z
LAST-MODIFIED:20260128T152020Z
UID:10001421-1769778000-1769783400@www.scilifelab.se
SUMMARY:Information seminar on KAW/SciLifeLab Proof of Concept call for grants 2026
DESCRIPTION:The 4th call for KAW/SciLifeLab Proof of Concept grants in Life Science is open for applications! \n\n\n\nThe purpose of the Proof of Concept grant is to bridge the gap from academic research to innovations in life science. The grant gives researchers the opportunity to develop their early-stage discoveries towards validated methods\, products or processes and  provides the opportunity to carry out activities that validate and accelerate the development of the project and prepare for innovation and commercialization. \n\n\n\nWatch the seminar below to learn more about the call. ↓ \n\n\n\nRegister to the Seminar\n\n\n\nProgram\n\n\n\n13.00The KAW/SciLifeLab Proof of Concept grants in Life Science\, Olli Kallioniemi\, Professor of Molecular Precision Medicine\, KI\, Lilian Wikström\, KAW13.20Project presentation – Marie Jeansson\, KITherapeutic intervention to slow progression of chronic kidney disease13.40Project presentation – Pål Stenmark\, Stockholm UniversityInnovative therapeutic toxins for the treatment of neuromuscular disorders14.00Open discussionModerator – Isolde Palombo\, KTH\n\n\n\nApplication period\n\n\n\nCall opens: January 13\, 2026Call closes: February 20\, 2026 at 13:00 \n\n\n\nRead more about the Call
URL:https://www.scilifelab.se/event/information-seminar-on-kaw-scilifelab-proof-of-concept-call-for-grants-2026/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/12/Proof-of-Concept_bulb-in-center.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251218T000000
DTEND;TZID=Europe/Stockholm:20251218T235900
DTSTAMP:20251202T124514Z
CREATED:20251202T123921Z
LAST-MODIFIED:20251202T124514Z
UID:10001677-1766016000-1766102340@www.scilifelab.se
SUMMARY:SciLifeLab PULSE - information webinar for applicants
DESCRIPTION:This webinar (two time options available) gives PULSE applicants an opportunity to receive information on e.g. the matchmaking and application process\, as well as eligibility rules. There will also be time for Q&A:s. Find out more about the SciLifeLab PULSE postdoc program here The 2nd SciLifeLab PULSE Call opened on December 15! \n\n\n\n\n\n\n\n\n\n\n\nWebinar registration\n\n\n\n\n\nWebinar on December 18\, 2025\, at 09:00 am\, UTC+1 \n\n\n\n\n\nRegister here\n\n\n\n\n\n\n\nWebinar on December 18\, 2025\, at 16:00 pm\, UTC+1 \n\n\n\n\n\nRegister here
URL:https://www.scilifelab.se/event/scilifelab-pulse-information-webinar-for-applicants/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2024/12/AdobeStock_519582269-scaled-1.jpeg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251216T151500
DTEND;TZID=Europe/Stockholm:20251216T161500
DTSTAMP:20251215T084907Z
CREATED:20251215T084843Z
LAST-MODIFIED:20251215T084907Z
UID:10001682-1765898100-1765901700@www.scilifelab.se
SUMMARY:[Spotlight Seminar Series] The innate power of natural killer cells in cancer therapy
DESCRIPTION:Professor Karl-Johan Malmberg (M.D. Ph.D) \, Oslo University \n\n\n\nBiography\n\n\n\nProfessor Karl-Johan Malmbergis a Specialist in Hematology with over 25 years of experience in NK cell research and cancer immunotherapy. He is the Director of a Norwegian Research Council Center of Excellence\, The Precision Immunotherapy Alliance (PRIMA) and leads an international team of 20 scientists based in laboratories both at the University of Oslo\, Norway and the Karolinska Institutet\, Sweden. He is also the Scientific Director of the Center for Advanced Cell and Gene Therapy (ACT) at Oslo University Hospital. The group focus on deciphering basic cellular and molecular mechanisms regulating NK cell function and seek to translate insights from these efforts in the design of novel approaches for NK-cell based cancer immunotherapy against cancer. \n\n\n\nRelevant Publications\n\n\n\nThe innate power of natural killer cells in cancer therapy. \n\n\n\nSohlberg E\, Malmberg KJ.Nat Med. 2025 Jun;31(6):1755-1756. doi: 10.1038/s41591-025-03712-9.PMID: 40355615 \n\n\n\nPan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. \n\n\n\nNetskar H\, Pfefferle A\, Goodridge JP\, Sohlberg E\, Dufva O\, Teichmann SA\, Brownlie D\, Michaëlsson J\, Marquardt N\, Clancy T\, Horowitz A\, Malmberg KJ.Nat Immunol. 2024 Aug;25(8):1445-1459. doi: 10.1038/s41590-024-01884-z. Epub 2024 Jul 2.PMID: 38956379 \n\n\n\n \n\n\n\nHost: Adnane Achour adnane.achour@ki.se
URL:https://www.scilifelab.se/event/spotlight-seminar-series-the-innate-power-of-natural-killer-cells-in-cancer-therapy/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2023/10/Campus-solna-seminar-picture.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251211T130000
DTEND;TZID=Europe/Stockholm:20251211T160000
DTSTAMP:20251211T084725Z
CREATED:20251027T112529Z
LAST-MODIFIED:20251211T084725Z
UID:10001654-1765458000-1765468800@www.scilifelab.se
SUMMARY:Science & SciLifeLab Prize Scientific Symposium 2025
DESCRIPTION:Welcome to the Scientific Symposium where the winners of the 2025 Science & SciLifeLab Prize for Young Scientists will present their research! \n\n\n\nScience\, the American Association for the Advancement of Science (AAAS)\, and SciLifeLab joined forces in 2013\, creating the Science & SciLifeLab Prize for Young Scientists to recognize excellence amongst young researchers from around the world. A global Prize aimed at rewarding scientists at an early stage of their careers. \n\n\n\nThe Prize is awarded in four different categories and the winners will be announced on November 14th \n\n\n\n\nUche Medoh\, Grand Prize Winner in Molecular Medicine\n\n\n\nLiam Lachs\, Category Winner in Ecology and Environment\n\n\n\nNitzan Tal\, Category Winner in Genomics\, Proteomics\, and Systems Biology Approaches\n\n\n\nKing L. Hung\, Category Winner in Cell and Molecular Biology\n\n\n\n\nAll four winners of the Science & SciLifeLab Prize for Young Scientists are invited to Sweden December 8-13 to participate in a unique week filled with events in honor of science. They will have the opportunity to meet with leading scientists in their field of research and create life-long connections to support their careers. \n\n\n\n \n\n\n\nThe symposium will take place at beautiful Grand Hôtel in Stockholm. \n\n\n\nSeats are limited so register today for your chance to meet with the winners and the the AAAS/Science editor team AND our honorary guest\, the Grand Prize Winner from 2024\, Andrija Sente. \n\n\n\nRegistration\n\n\n\nProgram\n\n\n\nScience SciLifeLab Prize SymposiumDownload\n\n\n\nRead more about the Prize\n\n\n\nRead more about the winners
URL:https://www.scilifelab.se/event/science-scilifelab-prize-scientific-symposium-2025/
LOCATION:Auditorium Stockholm\, Grand Hôtel\, Södra Blasieholmshamnen 8\, Stockholm\, 10327\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2020/05/prize_2018_puff.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251125T151500
DTEND;TZID=Europe/Stockholm:20251125T163000
DTSTAMP:20251112T145847Z
CREATED:20251110T125804Z
LAST-MODIFIED:20251112T145847Z
UID:10001662-1764083700-1764088200@www.scilifelab.se
SUMMARY:[Spotlight Seminar Series] Molecular Mechanisms Underlying the Energy Currents of Life
DESCRIPTION:Spotlight seminar series proudly welcomes Professor Vile R. I. Kaila to give a seminar at SciLifeLab Campus Solna. \n\n\n\n\n\n\n\nBiography\n\n\n\nVille R. I. Kaila received his PhD in biochemistry in 2009 from University of Helsinki. After a postdoc at the US National Institutes of Health (NIH)\, he was appointed a professorship at the Technical University of Munich in 2013. In 2019\, Kaila moved with his research group to Stockholm\, where he is currently professor at the Department of Biochemistry and Biophysics at Stockholm University and a Wallenberg Scholar. His research focuses on elucidating mechanistic principles of bioenergetic enzyme complexes by development of integrative computational and experimental approaches. Read more at http://villekaila.com/ \n\n\n\nAbstract\n\n\n\nBiological energy conversion is catalyzed by intricate protein complexes that transduce redox energy into proton currents across a biological membrane\, powering the cellular energy metabolism. Yet\, despite significant advances in recent years\, the molecular principles of these reactions remain poorly understood and pose major scientific challenges. In this talk\, I describe our integrative mechanistic exploration of complex bioenergetic machines\, where we combine multiscale simulations and data-driven methods with biophysical experiments and structural (cryo-EM) studies to derive a molecular understanding of intricate long-range charge transfer reactions in biology on a broad range of timescales and spatial resolutions. I describe our recent work on understanding enzymes catalyzing long-range charge transfer reaction by intrinsic electric field effects. We find that mutations of key residues mediating these allosteric processes lead to perturbed coupling effects\, and development of severe human diseases\, with striking similarities in different biological systems. \n\n\n\n \n\n\n\nHost: Marta Carroni marta.carroni@scilifelab.se
URL:https://www.scilifelab.se/event/spotlight-seminar-series-molecular-mechanisms-underlying-the-energy-currents-of-life/
LOCATION:Gamma 2 Lunchroom\, SciLifeLab\, Tomtebodavägen 23\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2023/10/Campus-solna-seminar-picture.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251021T153000
DTEND;TZID=Europe/Stockholm:20251021T170000
DTSTAMP:20251013T140807Z
CREATED:20251013T140805Z
LAST-MODIFIED:20251013T140807Z
UID:10001635-1761060600-1761066000@www.scilifelab.se
SUMMARY:Molecular Mechanism of RNA Splicing by the Spliceosome
DESCRIPTION:Seminar by Yigong ShiWestlake University\, Hangzhou\, Zhejiang 310024\, China \n\n\n\nHost: David Drew\, SciLifeLab \n\n\n\nSplicing of the precursor messenger RNA (pre-mRNA) is an indispensable step in the information flow from DNA to protein in all eukaryotes. Research of the past four decades has led to accumulation of a large body of biochemical and genetic information on pre-mRNA splicing. Structural information is central to the elucidation of the molecular mechanism of pre-mRNA splicing by the spliceosome. In 2015\, we reported the first atomic structure of an intact spliceosome from S. pombe at an average resolution of 3.6 Å. This structure reveals the overall organization and the conserved atomic features of an intact spliceosome\, which turns out to be a protein-orchestrated metalloribozyme. Since then\, atomic structures have been reported for nearly all major functional states of the spliceosome\, allowing recapitulation of the entire splicing cycle and mechanistic understanding of RNA splicing. In this presentation\, I will summarize these advances and discuss implications on disease treatment.
URL:https://www.scilifelab.se/event/molecular-mechanism-of-rna-splicing-by-the-spliceosome/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251016T090000
DTEND;TZID=Europe/Stockholm:20251016T170000
DTSTAMP:20251016T111054Z
CREATED:20250912T085114Z
LAST-MODIFIED:20251016T111054Z
UID:10001613-1760605200-1760634000@www.scilifelab.se
SUMMARY:Campus Solna Science Talks 2025
DESCRIPTION:Warmly welcome to the sixth Campus Solna Science Talk – a meeting for everyone in the community to learn more about ongoing research and activities at SciLifeLab’s Campus Solna\, which aims to bring the community together\, inspire exchange and new collaborations. \n\n\n\nResearch presentations will be given by group leaders and junior researchers (selected with consideration for balance in topics\, presenters’ career stages\, and affiliations) as part of four plenary sessions that will be mixed with panel discussions. We will end the day at Delta Campus Solna with poster sessions and pub. \n\n\n\nWe invite all Campus Solna research groups to be represented with at least 1 poster (and maximum 3). Furthermore\, we want to encourage all infrastructure units\, support functions (IT\, OO\, Site support) and committees (DEI\, Public Engagement\, CSI and the PhD&Postdoc Council) to partake with posters! \n\n\n\nSeats are limited\, register today to secure your spot! \n\n\n\nRegistration\n\n\n\n\n\n\n\nProgram\n8.45Welcoming and opening of symposiumPer Ljungdahl and Jan Ellenberg9.00Session I: Molecular profilingModerator: Erik Benson9.05Nanoscale detection and chemical targeting of DNA replication at its rootBennie Lemmens9.20Illuminating DNA-RNA connectomes in single cellsMagda Bienko9.35Proteome-wide biophysicsIlaria Piazza9.50Systematic Profiling of GPCR Autoantibodies in Human DiseaseMarcus Saarinen (Jochen Schwenk lab)10.10Coffee10.40Session II: Environment and EvolutionModerator: Christopher Wheat10.45Climate-Driven Trends in Adaptive Molt PhenologyTheodore Squires (Mafalda Sousa Ferreira lab)11.00Genomics of island lineages: A data-driven approachJose Cerca (DDLS Fellow)11.15How Development Makes Evolution More PredictableLisandro Milocco (DDLS fellow)11.35Putting CoARA and Research Assessment Reform into Practice: What It Means for SciLifeLab and Swedish ResearchChris Erdmann\, Annika Jenmalm Jensen\, Joanna Sendecka12.05Lunch12.50Session III: Membrane biology and molecular networksModerator: Rebecca Howard12.55Towards structure-guided design of mRNA lipid nanoparticlesWojciech Fijalkowski (Hanna Barriga lab)13.10Using biophysical properties of immune cells to find unifying biomarkers in long COVID and Chronic Fatigue Syndrome (ME/CFS)Agnes M. Koerfer (Erdinc Sezgin lab)13.25Combining cryo-EM and simulations to study membrane structureKaran Sharma (Milka Doktorova lab)13.40From Nodes to Distributed States: Tools to Decode Mammalian BehaviorStefanos Stagkourakis14.00Leg stretch and Coffee14.20Session IV: Machine learning and drug development Moderator: Brinton Seashore-Ludlow14.25PRIME: Investigating the role of PRostate Inflammation as a Mechanism for Cancer EvolutionAlexandra Rafeletou (Arian Lundberg lab)14.40Machine Learning methods for Cancer Research & Drug DiscoveryGolnaz Taheri14:55Navigation of vast chemical spaces for drug discoveryAndreas Luttens15.10Towards clinically reliable artificial intelligence for prostate cancer pathologyNita Mulliqi (Kimmo Kartasalo lab)15.30Panel: Evolution of SciLifeLab – 15 years! From Past into the FutureModerators; Rebecca Howard and Erdinc Sezgin16.00Concluding remarksPer Ljungdahl16.15Poster session and Pub at Campus Solna\n\n\n\n\nPosters\nThere will be voting for the Best Poster Award in two different categories; “Best Design and Presentation” and “Highest Scientific Impact”. The winners will be announced towards the end of the poster session. \n\n\n\n \n\n\n\nEach group/unit is welcome to bring up to 3 posters to the grand Poster Session that will follow the talks. Submit the poster titles in the registration form. Please coordinate within your research group/unit beforehand who should bring a poster. \n\n\n\nPlease add your building and floor to the poster\, so that everyone knows where your research is taking place. \n\n\n\nPoster size; A0 or smaller in portrait orientation \n\n\n\nPosterlista Science Talks 2025Download\n\n\n\n\nScientific committee\nInci Aksoylu \n\n\n\nHaris Babačić \n\n\n\nIskra Pollack \n\n\n\nAdnane Achour \n\n\n\nErik Benson \n\n\n\nPer Ljungdahl \n\n\n\nOrganising committe\n\n\n\nDisa Hammarlöf \n\n\n\nIsolde Palombo
URL:https://www.scilifelab.se/event/campus-solna-science-talks-2025/
LOCATION:Life City\, Solnavägen 3H\, Stockholm\, 113 64
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2022/09/Fasad-SciLifeLab-Solna-2022-2-1-scaled.jpeg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251002T150000
DTEND;TZID=Europe/Stockholm:20251002T160000
DTSTAMP:20250926T084643Z
CREATED:20250926T084640Z
LAST-MODIFIED:20250926T084643Z
UID:10001620-1759417200-1759420800@www.scilifelab.se
SUMMARY:Basic and Translational Research on Fungal-Host Interactions
DESCRIPTION:Changbin Chen\, Professor \n\n\n\nUnit of Pathogenic Fungal Infection & Host ImmunityShanghai Institute of Immunity and Infection\, Chinese Academy of Sciences\, Shanghai\, China \n\n\n\nProf. Changbin Chen is visiting SciLifeLab Campus Solna as part of a NSFC and STINT funded collaboration with the Ljungdahl laboratory.  \n\n\n\nProject:  Role of amino acid acquisition and catabolism as drivers of virulent Candida auris infections. \n\n\n\nThe Shanghai Institute of Immunity and Infection has assembled an impressive array of analytic infrastructures\, similar in breath available at SciLifeLab\, to address mechanistic aspects of infectious disease. \n\n\n\nProf. Chen will present how his laboratory and collaborators examine the virulence properties of fungal pathogens in context of mammalian hosts. \n\n\n\nHost: Per Ljungdahl \n\n\n\nRoom: Big
URL:https://www.scilifelab.se/event/basic-and-translational-research-on-fungal-host-interactions/
LOCATION:SciLifeLab Campus Solna\, Tomtebodavägen 23 A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20251001T090000
DTEND;TZID=Europe/Stockholm:20251001T170000
DTSTAMP:20250929T172603Z
CREATED:20241101T094230Z
LAST-MODIFIED:20250929T172603Z
UID:10001393-1759309200-1759338000@www.scilifelab.se
SUMMARY:Disruptive Technologies for Drugging the Undruggable
DESCRIPTION:SciLifeLab Science Summit 2025 \n\n\n\n\n\n\n\nAre you ready to explore the cutting-edge for the future of drug discovery? Mark your calendar for the SciLifeLab Science Summit 2025\, an event focusing on novel technologies as drivers to find new modalities for disease intervention and drug innovation for precision medicine. \n\n\n\nThis full-day symposium will bring together leading scientists\, industry experts\, and innovators to discuss the breakthroughs and challenges in addressing previously inaccessible drug targets. Join us at Aula Medica\, Karolinska Institutet\, for a packed program featuring high-impact international presentations\, panel discussions\, and networking opportunities. \n\n\n\nJunior researchers are encouraged to participate with poster presentations – with the opportunity to be selected to give a short talk. \n\n\n\nProgram\n\n\n\n08:45Registration09:30Welcome wordsIntroduction of the day09:40SciLifeLab – a fertile ground for innovationMia Phillipson\, SciLifeLab09:50Any target\, every time: how proximity-based drugs are redefining pharmacotherapyRay Deshaies\, Amgen / Caltech10:40Coffee break & poster session ISee Poster List & Abstracts here11:25Applying lessons learned from Duchenne exon skipping dystrophy to developing exon skipping for patients with nanorare diseasesAnnemieke Aartsma-Rus\, Leiden University Medical Center12:00Oligonucleotide therapy – from bench to besideAnders Gabrielsen\, Ribocure Pharmaceuticals12:10Empowering immunotherapy with cellular reprogrammingFilipe Pereira\, Lund university12:20Conclusions12:30Lunch & Poster Session13:40AI and machine learning for next-generation drug discoveryEva Nittinger\, AstraZeneca14:10Electrophoretic Implants for in situ Precision MedicineTheresia Arbring Sjöström\, Linköping University14:15Integrated Hit Discovery Pipeline Targeting Protein–Protein InteractionsFlorian David\, Chalmers University of Technology14:20Employing CETSA in primary screening for P53 bindersMerve Kacal\, Pelago Bioscience AB14:25Capturing Conformational Change : A Strategy for Drugging Dynamic Transporters\, Receptors and Ion ChannelsDarko Mitrovic\, KTH Royal Institute of Technology14:30Conclusions14:40Coffee break & poster session IISee poster list and abstract here15:30Encoded combinatorial libraries and the dream of Paul EhrlichDario Neri\, Philogen / ETHZ16:00The 2025 Drug Discovery and Development PipelineJessica Martinsson\, SwedenBio16:20Panel discussion16:40Wrap-up\, best poster award17:00Mingle\n\n\n\nPrintable program Science Summit 2025Download\n\n\n\n\n\n\n\nResearch Infrastructures and Research Posters\n\n\n\nPoster abstract book\, Science Summit 2025Download\n\n\n\nCompany Exhibition\n\n\n\n15 companies will present their technologies in the exhibition area. \n\n\n\nBICO\, Epistat\, Sino Biological Europe GmbH\, Chempartner\, Ramcon\, Twist Bioscience\, Shimadzu\, Teknolab Sorbent AB\, BioNordika Sweden AB\, Berner Lab\, Kem-En-Tec Nordic \, Eppendorf Nordic\, LabLife Nordic  \n\n\n\n\n\n\n\n\n\n \n\n\n\nScientific Committee\n\n\n\n\nClaes Wahlestedt\, University of Miami\n\n\n\nMalin Lemurell\, AstraZeneca\n\n\n\nAlexandra Teleki\, Uppsala University\n\n\n\n\n \n\n\n\n\n\n \n\n\n\nOrganizing Committee\n\n\n\n\nPer Arvidsson\, Karolinska Institutet/SciLifeLab\n\n\n\nRebecka Klintenberg\, Uppsala University/SciLifeLab\n\n\n\nMats Ohlin\, Lund University/SciLifeLab\n\n\n\nKristian Sandberg\, Uppsala University/SciLifeLab\n\n\n\nContact: David Gotthold\, SciLifeLab
URL:https://www.scilifelab.se/event/drugging-the-undruggable-scilifelab-science-summit-2025/
LOCATION:Aula Medica\, Nobels väg 6\, Solna
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2024/11/Webpuff-Science-Summit-2025.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250923T151500
DTEND;TZID=Europe/Stockholm:20250923T161500
DTSTAMP:20250908T101409Z
CREATED:20250908T101407Z
LAST-MODIFIED:20250908T101409Z
UID:10001612-1758640500-1758644100@www.scilifelab.se
SUMMARY:[Spotlight seminar] Systems Human Immunology and AI: Immune Setpoint and Immune Health
DESCRIPTION:Speaker: Professor John Tsang\, Yale University \n\n\n\nAbstract\n\n\n\nThe immune system\, critical for human health and implicated in many diseases\, defends against pathogens\, monitors physiological stress\, and maintains tissue and organismal homeostasis. It exhibits substantial variability both within and across individuals and populations. Recent technological and conceptual progress in systems human immunology has provided predictive insights that link personal immune states to intervention responses and disease susceptibilities. Artificial intelligence (AI)\, particularly machine learning (ML)\, has emerged as a powerful tool for analyzing complex immune data sets\, revealing hidden patterns across biological scales\, and enabling predictive models for individualistic immune responses and potentially personalized interventions. Here I light our recent work in deciphering human immune variation and predicting outcomes\, particularly through the concepts of immune setpoint\, immune health\, and use of the immune system as a window for measuring health.  \n\n\n\nBiography\n\n\n\nJohn Tsang is a systems immunologist\, computational biologist\, and engineer. He is the Anthony N. Brady Professor of Immunobiology and Biomedical Engineering at Yale University\, the Founding Director of the Yale Center for Systems and Engineering Immunology (CSEI)\, the Yale Lead and an Investigator at the Chan Zuckerberg Biohub New York\, and the co-Chief Scientific Officer of the Human Immunome Project (a non-profit dedicated to mapping human immune variation around the globe to develop AI models of human immune health for the benefit of all). Tsang has pioneered and established the concepts and predictive metrics of human immune setpoints and immune health including responses to vaccines\, infections\, autoimmunity\, and therapeutics in human populations spanning the lifespan from infancy to old age. Tsang is also interested in programming immune cells to enable longitudinal immune and health monitoring of the entire body. Tsang has received numerous awards including multiple NIH Merit Awards for his research and leadership in systems immunology\, COVID-19\, and human immunology. He has advised numerous programs and organizations\, including the Allen Institute\, the Gates Foundation\, CEPI\, World Allergy Organization\, National Cancer Institute\, National Institute of Allergy and Infectious Diseases\, National Institute of Diabetes and Digestive and Kidney Diseases\, Snow Medical (Australia)\, and the Walter and Eliza Hall Institute (Australia). Tsang earned his Ph.D. in biophysics from Harvard University and trained in computer engineering (BASc) and computer science (MMath) at the University of Waterloo\, Canada.  \n\n\n\nHost: burcu.ayoglu@scilifelab.se
URL:https://www.scilifelab.se/event/spotlight-seminar-systems-human-immunology-and-ai-immune-setpoint-and-immune-health/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2023/10/Campus-solna-seminar-picture.jpg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250918T110000
DTEND;TZID=Europe/Stockholm:20250919T130000
DTSTAMP:20250918T033327Z
CREATED:20241101T121408Z
LAST-MODIFIED:20250918T033327Z
UID:10001394-1758193200-1758286800@www.scilifelab.se
SUMMARY:SciLifeLab Group Leader Retreat
DESCRIPTION:To SciLifeLab Group Leaders: Join us at this enriching retreat to contribute to a collaborative culture and advance cutting-edge life science research in Sweden and beyond. \n\n\n\nThis retreat offers SciLifeLab Group Leaders an opportunity to come together in an informal setting\, exchange ideas\, and explore opportunities for collaboration that transcend the boundaries of individual disciplines\, universities\, and research units. The program will focus on three key themes: \n\n\n\nThe registration is closed! \n\n\n\nThe Future of Life Science \n\n\n\nKeynote: Jan Ellenberg\, SciLifeLab Director – “Future of Life Sciences”. Panel Talk\, Audience Interaction\, and Group Discussions. Moderator: Ola Spjuth. \n\n\n\nSciLifeLab Development of and Access to Cutting-Edge Technologies \n\n\n\nInspirational Talks in Thematic areas followed by Group Discussions. \n\n\n\n\nSpatial Omics – EventArenaModerators: Markus Heidenblad and Stefania Giacomello. Speaker: Charlotte Stadler\n\n\n\nTechnology for Biodiversity – Wijk 1Moderators: Mafalda Sousa Ferreira and Gabriela Montejo-Kovacevich. Speaker: Marc Friedländer\n\n\n\nAI & Modelling – Wijk 4Moderators: Carolina Wählby and Björn Wallner. Speaker: Gunnar Cedersund\n\n\n\nImaging Structure Function In Situ / Cryo-EM / Organoids – Wijk5 Moderators: Linda Sandblad and Gunnar von Heijne. Speaker: Marta Carroni\n\n\n\n\nLeadership into the Future \n\n\n\nKeynote: Ronnie Berntsson\, Umeå University. Interactive group exchanges on leadership strategies. Moderator: Bianca Stenmark and Valtteri Wirta. \n\n\n\nDetails:\n\n\n\nDate: September 18-19\, 2025 \n\n\n\nStart: Sept. 18 at 10:00 \n\n\n\nEnd: Sept. 19 at 15:00 \n\n\n\nVenue: Skogshem & Wijk\, Lidingö\, Stockholm (map) \n\n\n\nFind your way! How to get there and a map of the Venue\, including parking spaces. \n\n\n\nBusses\n\n\n\nTo Skogshem & Wijk – September 18 FromDepartureSciLifeLab Uppsala (BMC)\, Husargatan 3\, entrance C1108:45Stockholm\, Cityterminalen09:30Stockholm\, Cityterminalen11:00From Skogshem & Wijk – September 19 ToDepartureSciLifeLab Uppsala (BMC)\, Husargatan 3\, entrance C1115:30Stockholm\, Cityterminalen15:30\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nGroup leader retreat_program_cleanDownload
URL:https://www.scilifelab.se/event/scilifelab-group-leader-retreat-2/
LOCATION:Skogshem & Wijk\, Hustegavägen 1\, Lidingö\, 181 24
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2024/11/Skogshem-wijk-view.jpeg
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
END:VCALENDAR